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A B S T R A C T
Background
The vast majority of people infected with human immunodeficiency virus (HIV) are adults of working age. Therefore unemployment
and job loss resulting from HIV infection are major public health and economic concerns. Return to work (RTW) after diagnosis of
HIV is a long and complex process, particularly if the individual has been absent from work for long periods. There have been various
efforts to improve the RTW of persons living with HIV (HIV+), and many of these have been assessed formally in intervention studies.
Objectives
To evaluate the effect of interventions aimed at sustaining and improving employment in HIV+ persons.
Search methods
We conducted a comprehensive search from 1981 until December 2014 in the following databases: Cochrane Central Register of
Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, OSH UPDATE databases (CISDOC, HSELINE, NIOSHTIC,
NIOSHTIC-2, RILOSH), and PsycINFO.
Selection criteria
We considered for inclusion all randomized controlled trials (RCTs) or controlled before-after (CBA) studies assessing the effectiveness
of pharmacological, vocational and psychological interventions with HIV+ working-aged (16 years or older) participants that had used
RTW or other indices of employment as outcomes.
Data collection and analysis
Two review authors independently screened all potential references for inclusion. We determined final selection of studies by consensus.
We performed data extraction and management, as well as Risk of bias assessment, in duplicate. We measured the treatment effect
using odds ratio (OR) for binary outcomes and mean difference (MD) for continuous outcomes. We applied the GRADE approach
to appraise the quality of the evidence.
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Main results
We found one RCT with 174 participants and five CBAs with 48,058 participants assessing the effectiveness of vocational training (n
= 1) and antiretroviral therapy (ART) (n = 5). We found no studies assessing psychological interventions. The one RCT was conducted
in the United States; the five CBA studies were conducted in South Africa, India, Kenya, and Uganda. We graded all six studies as
having a high risk of bias.
The effectiveness of vocational intervention was assessed in only one study but we could not infer the intervention effect due to a lack
of data.
For pharmacological interventions, we found very low-quality evidence for a beneficial effect of ART on employment outcomes in five
studies. Due to differences in outcome measurement we could only combine the results of two studies in a meta-analysis.
Two studies compared employment outcomes of HIV+ persons on ART therapy to healthy controls. One study found a MD of -
1.22 days worked per month (95% confidence interval (CI) -1.74 to -1.07) at 24-months follow-up. The other study found that the
likelihood of being employed steadily increased for HIV+ persons compared to healthy individuals from ART initiation (OR 0.35,
95% CI 0.26 to 0.47) to three- to five-years follow-up (OR 0.73, 95% CI 0.42 to 1.28).
Three other studies compared HIV+ persons on ART to HIV+ persons not yet on ART. Two studies indicated an increase in the
likelihood of employment over time due to the impact of ART for HIV+ persons compared to HIV+ persons pre-ART (OR 1.75, 95%
CI 1.44 to 2.12). One study found that the group on ART worked 12.1 hours more (95% CI 6.99 to 17.21) per week at 24-months
follow-up than the average of the cohort of ART and pre-ART HIV+ persons which was 20.1 hours.
We rated the evidence as very low quality for all comparisons due to a high risk of bias.
Authors’ conclusions
We found very low-quality evidence showing that ART interventions may improve employment outcomes for HIV+ persons. For
vocational interventions, the one included study produced no evidence of an intervention effect. We found no studies that assessed
psychological interventions. We need more high-quality, preferably randomized studies to assess the effectiveness of RTW interventions
for HIV+ persons.
P L A I N L A N G U A G E S U M M A R Y
Interventions for improving employment outcomes for workers with HIV
Background
For people living with HIV(HIV+), losing their job can make it even harder to cope with the illness. This review aimed to assess how
we can prevent HIV+ people from losing their jobs or help them return to work. There are three approaches to achieve these aims.
The first one is to use drugs, meaning antiretroviral therapy, to keep the disease and its symptoms from getting worse. The second is to
make changes to work tasks or the work environment. The third is to offer psychological support to help the HIV+ person cope better
with their condition, especially at work. We included studies that assessed the effects of one or more of these approaches. The effect of
interventions can be measured as whether HIV+ persons are employed or not, and as the number of days or hours HIV+ persons were
able to work following an intervention.
Studies we found
We found five controlled before-after (CBA) studies from South Africa, India, Uganda, and Kenya and one randomized controlled trial
from the USA. The studies included over 48,000 participants. Five studies examined antiretroviral therapy and one study examined
vocational interventions as a way of improving return to work in HIV+ people.
Key findings
The five CBA studies found that antiretroviral therapy interventions may increase employment outcomes in HIV+ people. One study
assessed the effect of making changes to work tasks or the work environment but did not report enough data to say if it helped or not.
We found no studies on psychological support to help HIV+ people cope better.
Quality of the evidence
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Overall, we found very low-quality evidence because the included studies all had a high risk of bias.
Conclusion
We found very low-quality evidence that antiretroviral therapy interventions could improve employment outcomes for HIV+ people.
We need high-quality, randomized trials to find out if pharmacological, vocational, and psychological interventions can improve
employment outcomes for HIV+ people.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Anti-retroviral therapy compared with no ART for HIV
Patient or population: Working age adults with HIV
Settings: Uganda
Intervention: ART
Comparison: Not on ART
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed Likelihood Corresponding Likeli-
hood
Not on ART Anti-retroviral therapy
(ART)
Employed at 12 months
follow-up
710 per 1000 811 per 1000
(779 to 838)
OR 1.75 (1.44 to 2.12) 1084
(2 studies)
⊕©©©
very low¹
*The basis for the assumed likelihood (e.g. the median control group risk across studies) is provided in footnotes. The corresponding likelihood (and its 95% confidence interval) is based
on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RR: Risk Ratio; ART: Anti-retroviral therapy
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
¹ Downgraded the quality of evidence because of limitations in study design as a non-randomized studies, as well as a high risk of bias
for baseline comparability, unclear risk for incomplete outcome data due to a lack of reporting of attrition for controls, and high risk
for adjustment for confounding .
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B A C K G R O U N D
As the vast majority of those infected with human immunodefi-
ciency virus (HIV) are adults of working age, unemployment and
job loss resulting from HIV infection are major public health and
economic concerns (Braveman 2006; Kaiser Family Foundation
2007; Yelin 1991).
The HIV literature suggests that HIV infection in individuals
of working age is associated with loss of employment, particu-
larly in women (Dray-Spira 2006). As with other serious illnesses,
HIV also leads to increased absenteeism from work, reduced pro-
ductivity, increased financial burden on employers, increased job
loss, and loss of earnings (Feeley 2004; Fox 2004; Kaiser Family
Foundation 2007; Sendi 2004). However, recent advances in the
treatment and management of the disease in the last decade have
made it possible for infected people to live longer and have health-
ier lives. As a result, HIV infection can now be considered a long-
term illness rather than a terminal one.
The benefits of employment on the health and social well-being
of adults of working age has been documented by, among others,
Rueda 2012 and Waddell 2006. Generally, frequent or long-term
absence from work leads to job loss and may result in depression,
financial insecurity, and social isolation (Henderson 2005; Linn
1985). Unemployment has been linked to suicidal tendencies and
poor memory performance, especially in men with HIV (Kelly
1998; Rabkin 2004). A study carried out by Blalock 2002 showed
that employment in people living with HIV was associated with
improvement in quality of life, positive effect on self esteem, and
increased confidence and dignity.
Barriers to return to work
Return to work (RTW) after diagnosis of HIV is a long and com-
plex process, particularly if the individual has been absent from
work for long periods (Gorman 2009). Several factors have been
identified in the current literature as barriers to RTW in HIV-
infected individuals. These include health concerns, such as un-
predictability of the disease, which is often associated with re-
peated episodes of illness leading to physical and cognitive impair-
ment; side effects of medication; and the fear of losing disability al-
lowance following RTW (Braveman 2006; Gorman 2009). Other
factors include the fear of discrimination and stigmatization at the
workplace by one’s employer and colleagues following disclosure
of HIV/AIDS status (Rabkin 2004; Rao 2008; Rodger 2010).
In the last decade, international organizations have made great
headway in addressing the barriers associated with RTW for those
living with HIV, particularly barriers related to the workplace. The
International Labour Organization’s ’Recommendation Concern-
ing HIV and AIDS and the World of Work’, in ILO 2010, and
’Code of Practice on HIV/AIDS and the World of Work’, in ILO
2001, set out recommendations and good practice. These include
such principles as non-discrimination in employment, promotion
of retention in work of people living with HIV, respect for the
human right and dignity of people living with HIV, and universal
access to prevention, treatment, care, and support. These recom-
mendations are meant to be used as the basis for policy develop-
ment in addressing the epidemic at the workplace (ILO 2001; ILO
2010).
Description of the intervention
Generally speaking, interventions that promote return to work for
any sick person include all activities undertaken to improve the
work ability of that individual. These activities often include inter-
ventions targeted at the employee, employer, and the workplace.
A number of arrangements and interventions have been investi-
gated in relation to sustaining employment in people living with
HIV. Kielhofner 2004 conducted a three-year RTW program for
people living with HIV using a combination of psycho-educa-
tional and occupational therapy. The authors concluded that this
approach addressed a wide range of physical, psychosocial, and
environmental issues.
Different types of vocational and psychosocial rehabilitation have
been investigated in relation to return to work for people living
with HIV. Although most of these studies have been qualitative
in nature, the results have been positive. In one study that inves-
tigated the impact of vocational services on employment in peo-
ple living with HIV/AIDS, the authors reported that vocational
services had a positive impact on employment (Conyers 2004).
TheMatrix Research Institute (MRI) conducted theKirk Employ-
ment Empowerment Project (KEEP), a vocational rehabilitation
practices demonstration project for HIV+ persons and employ-
ment. KEEP’smultidimensional intervention service approach in-
cluded job search assistance, benefits and legal counselling, dis-
ability management education, on-site job support, job-related
problem solving, skills training, referrals to auxiliary services, and
coordination of other service providers. The MRI results demon-
strated improvement in employment outcomes due to vocational
rehabilitation services (Escovitz 2005). Group counselling as an
intervention aimed at enhancing RTW has also been found to
impact positively on RTW in HIV+ persons. Kohlenberg 2003
investigated group counselling as an intervention to support RTW
in people living with HIV with physical and cognitive symptoms.
A significant aspect of this intervention involved the development
of personalized occupational training and employment plans.
Additionally, researchers have examined the use of antiretroviral
therapy (ART) in employment retention and re-entry. Pharma-
cological interventions such as ART exhibit compelling results in
improving the likelihood of employment-related economic pro-
ductivity for HIV+ persons (Bernell 2005; Van der Borght 2006).
Why it is important to do this review
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Successful RTW or sustainability of employment in HIV+ de-
pends not only on co-operation between the employer and the
employee, but also the availability of evidence-based interventions
that encourage and promote return to work. Although there are
several reviews on interventions that promote RTW following di-
agnosis of long-term conditions such as cancer and musculoskele-
tal problems (De Boer 2011; Schaafsma 2010), no systematic re-
view has been published that looks specifically at interventions
aimed at promoting RTW or sustaining employment for HIV+
persons.
O B J E C T I V E S
To evaluate the effect of interventions aimed at sustaining and
improving employment in HIV+ persons.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We assessed all eligible randomized controlled trials (RCTs) for in-
clusion in this review. However, due to the complexity of conduct-
ing RCTs in work organizations, we also accepted cluster RCTs
and controlled before-after (CBA) studies.
Types of participants
We included studies conducted with HIV+ persons aged 16 years
and over who were employed or unemployed at the time of diag-
nosis, irrespective of the stage of disease at the time of diagnosis.
Types of interventions
We included studies that evaluated any intervention or arrange-
ment aimed at sustaining work or employment in people living
with HIV. We considered interventions that were targeted at the
workplace or at the individual or groups of individuals within the
workplace or community, including policies aimed at preserving
employment in specific categories of workers. We categorized in-
terventions as follows:
1. Medical or pharmacological interventions such as provision
of free ART or antidepressants.
2. Vocational interventions such as vocational or occupational
rehabilitation, workplace adjustments such as protected time for
medication, change in work schedule or duties, modified work
hours, or improved communication with or between managers,
colleagues, and health professionals.
3. Psychological interventions such as education, counselling,
cognitive-behavioral interventions, training in coping skills, or
group psychotherapy.
4. A combination of any of the above.
Types of outcome measures
Primary outcomes
1. RTW, measured either as the number of days to partial or
full work resumption or as the number of days absent during
follow-up.
2. Job loss, measured as the number of people who lost their
job during the time of follow-up. As the complement of job loss
is being employed, we also included studies that had measured
being employed or the amount of time spent at work.
Secondary outcomes
1. Overall quality of life (physical and emotional).
2. Cost of intervention programs and cost effectiveness of
RTW or employment.
Search methods for identification of studies
Electronic searches
We searched for relevant studies in the following databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL; 2014, Issue 12)
• MEDLINE (1980 to December 2014)
• EMBASE (1980 to December 2014)
• CINAHL (1983 to December 2014)
• OSH UPDATE databases (CISDOC, HSELINE,
NIOSHTIC, NIOSHTIC-2, RILOSH; 1980 to present)
• PsycINFO (1980 December 2014)
We have presented the search strategies for MEDLINE, CEN-
TRAL, EMBASE, and OSH UPDATE as Appendix 1, Appendix
2, Appendix 3, and Appendix 4. We designed the strategies to in-
clude appropriateMeSH subject headings and text word terms, in-
terventions under consideration, and included study designs. We
restricted the searches to years from 1981 onwards, reflecting the
year when the first acquired immunodeficiency syndrome (AIDS)
cases were reported in the United States. We imposed no language
restrictions.
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Searching other resources
We screened the reference lists of selected articles and reviews to
locate additional potentially eligible studies.
We considered articles and studies published in any language. We
intended for relevant articles published in languages other than
English to be translated, but we found no such articles. When we
required further information to determine inclusion, we wrote to
the corresponding authors.
Data collection and analysis
Selection of studies
We carried out the selection of eligible studies in two stages.
Stage 1: Three review authors (Rachel Robinson (RR), Em-
manuelOkpo (EO), andNomusaMngoma (NM)) independently
screened the titles and abstracts of studies the search strategy iden-
tified for relevance, that is whether the study assessed the effective-
ness of an intervention aimed at sustaining employment in HIV-
infected individuals and measured RTW. If the title and abstract
provided sufficient information to determine that the study did
not satisfy the criteria for inclusion, we excluded the study. Review
authors resolved differences in opinion through discussion.
Stage 2: We retrieved full texts of all the studies selected in stage
1. Each review author then independently examined whether the
selected studies met the inclusion criteria. At this stage, we doc-
umented the reasons for study exclusion. We resolved differences
in opinion by discussion and consensus.
We have presented a PRISMA study flow diagram to describe
the sequence of steps in the screening process and reasons for the
exclusion of studies in Figure 1.
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Figure 1. PRISMA study flow diagram
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Data extraction and management
We designed a data extraction form specifically for this review that
captured key elements such as study design, country, setting, so-
ciodemographic characteristics of participants including ethnic-
ity, interventions (content, duration, provider, context), follow-
up, and all outcomes of interest, particularly RTW measures. Re-
view authors (RR, EO, and NM) independently extracted data
from the eligible studies.
Assessment of risk of bias in included studies
All three review authors (RR, EO, and NM) independently as-
sessed the risk of bias of all the included studies by following the
procedures described in the Cochrane Handbook for Systematic Re-
views of Interventions (Higgins 2011). We assessed RCTs and clus-
ter RCTs against the six domains listed below. We rated studies as
having ’low risk of bias’ (plausible bias unlikely to seriously alter
the results); ’high risk of bias’ (plausible bias that seriously weakens
confidence in the results); or ’unclear risk of bias’ (plausible bias
that raises some doubt about results).
• Sequence generation: Was the allocation sequence
adequately described?
• Allocation concealment: Was allocation adequately
concealed?
• Blinding of participants, personnel, and outcome assessors:
Was knowledge of the allocation intervention adequately
prevented during the study?
• Incomplete outcome data: Was incomplete outcome data
adequately addressed?
• Selective outcome reporting: Are reports of the study free of
suggestion of selective outcome reporting?
• Other sources of bias: Did the study appear to be free of
other problems that could put it at high risk of bias?
For non-randomized studies, we utilized the checklist developed
by Downs 1998 to measure the quality of the studies. The criteria
consist of several scales, but our review team used only the follow-
ing two:
• Internal validity in terms of bias (seven items)
• Internal validity in terms of confounding and selection bias
(six items)
We added an additional item on baseline comparability of inter-
vention and control group, but we did not use the item on power
of the study. We combined all items with the Cochrane ’Risk of
bias’ tool in the Characteristics of included studies section. For
confounding and baseline comparability, we used the following
factors that according to our judgment could increase or decrease
employment: gender, age, socioeconomic status, migration status,
disease severity.
Instead of the original score as ’yes’, ’no’, or ’unable to determine’,
we used ’low’, ’high’, and ’unclear’ risk of bias tomake the checklist
compatible with the Cochrane ’Risk of bias’ tool as implemented
in RevMan 2014.
We determined blinding of participants to be ’low risk’ for ret-
rospective studies because participants were unaware of the inter-
vention at the time. Conversely, we considered blinding of par-
ticipants to be ’high risk’ if study authors did not report having
used blinding or if it was clear from the report that the study was
unblinded. See point 14 in our ’Risk of bias’ assessments in the
Characteristics of included studies section.
Measures of treatment effect
We plotted the results of each study as point estimates. For binary
outcomes, that iswhere the probability of an event occurring or not
occurring is considered, we used risk ratios (RRs) as the measure
of effect; if this was not reported, we used odds ratios (ORs). For
continuous outcomes, we plotted the results of individual studies
using mean differences (MDs). The reporting of effect sizes did
not require the use of standardized mean difference as we found
no studies using similar continuous outcome measures. When we
could not plot the results, we described them in the text.
Unit of analysis issues
As we found no cluster RCTs to include in the review, we did not
have to contend with unit of analysis problems.
If in future updates we encounter studies that employ a cluster-
randomized design and that report sufficient data for us to in-
clude in the meta-analysis but do not make an allowance for the
design effect, we will calculate the design effect based on a fairly
large assumed intracluster correlation of 0.10. We based this as-
sumption of 0.10 being a realistic estimate by analogy on studies
about implementation research (Campbell 2001). We will follow
the methods stated in the Cochrane Handbook for Systematic Re-
views of Interventions for the calculations (Higgins 2011).
If in future updates we find studies with repeat observations on
participants, we will compute an effect measure for each partici-
pant factoring in all the time points and will present this as trends
over time or overall means, depending on the data.
Dealing with missing data
When the issue of missing data arose, we discussed the reasons
why the data could be missing and determined a way of dealing
with it accordingly. Where we suspected missing data due to a lack
of publication, publication in obscure places, or data presented in-
appropriately, we did whatever was possible to contact the original
authors of the studies.
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If in future updates of this review we discover that participants are
missing from the reported results, such as when analyses of ran-
domized trials do not include all randomized participants (no in-
tention-to-treat analyses), we will consider performing intention-
to-treat analysis on the presented data. We will also consider:
• analyzing only the available data (i.e. ignoring the missing
data);
• imputing the missing data with replacement values and
treating these as if they were observed;
• imputing the missing data and accounting for the fact that
these were imputed with uncertainty;
• using statistical models to allow for missing data while
making assumptions about their relationships with the available
data.
We will explicitly state the assumptions of any methods used to
cope with missing data and perform sensitivity analyses to assess
how sensitive results are to changes in the assumptions.
Assessment of heterogeneity
We assessed clinical homogeneity based on similarity the of popu-
lation, intervention, outcome, and follow-up.We considered pop-
ulations as similar when they were people living with HIV aged
16 years and over irrespective of the stage of the disease at the time
of diagnosis. We considered the various intervention categories (as
outlined in Types of interventions) as different. We deemed the
various outcome categories as different. For the RTW outcome,
both the number of days to partial or full work resumption and
number of days absent during follow-up had to be sufficiently
similar to combine them as similar outcomes. We regarded follow-
up times as different if they were less than three months, three
months to one year, and more than one year.
In conducting meta-analyses, we considered the extent to which
the results of studies are consistent by comparing confidence in-
tervals for the results of individual studies and observing overlap
as indication of the presence of statistical heterogeneity. We per-
formed a Chi² test to further check for statistical heterogeneity.
When the P value indicated that there was heterogeneity, we used
the result of the I² measure to quantify the degree of heterogeneity.
A percentage of 0% to 40% indicated that heterogeneity might
not be important; 30% to 60% signifed moderate heterogeneity;
50% to 90% substantial heterogeneity; and 75% to 100% con-
siderable heterogeneity.
Assessment of reporting biases
We compared the outcomes listed in the methods section of an
article with the reported results. We considered inadequately re-
ported, non-significant results as a potential source of bias. We in-
cluded published and unpublished data on the intervention under
review to reduce publication bias. If sufficient data are available in
future updates of this review, we will use funnel plots to detect re-
porting bias. We reduced the effect of reporting bias by including
studies and not publications in order to avoid the introduction
of duplicated data (that is two articles could represent duplicate
publications of the same study). Following the Cho 2000 state-
ment on redundant publications, we extracted data only once for
duplicate studies or if multiple articles reported on the same study.
We prevented location bias by searching across multiple databases.
Additionally, we prevented language bias by not excluding any ar-
ticle based on language.
Data synthesis
As this review includes different types of studies (randomized and
non-randomized studies), we analysed the data separately for the
different study designs. We pooled suitably homogenuous data
using Review Manager 5.3 software (RevMan 2014). We present
the results of our only meta-analysis in the Summary of findings
for the main comparison.
We had sufficient data to performmeta-analysis based on only two
studies. As the two studies included in the meta-analysis were sta-
tistically homogeneous, we used a fixed-effect model.We included
the 95% confidence interval (CI) around the effect estimate. In fu-
ture updates of the review, if studies are heterogenous, we will use
a random-effects model. When using the random-effects model,
we will conduct a sensitivity check by using the fixed-effect model
to reveal differences in results.
We assessed the quality of evidence using the GRADE approach
as described in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). See additional Table 1.
We downgraded the quality of evidence for the RTW outcome
based on the following factors:
• Limitations of the study design and implementation:
allocation concealment, blinding, loss to follow-up, and selective
reporting
• Indirectness of evidence: indirect population, intervention,
control, and outcomes
• Inconsistency of results: subgroup analysis, heterogeneity,
and inconsistent results
• Imprecision of results: wide confidence intervals
• Publication bias
We considered upgrading the quality of evidence for CBA studies
based on the following factors:
• Magnitude of the effect
• Dose-effect relation
• All confounding excluded
The GRADE approach specifies four levels of quality (high, mod-
erate, low, and very low).
Subgroup analysis and investigation of heterogeneity
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Although we had planned to carry out a series of subgroup analy-
ses, the included studies did not provide sufficient data to do so.
In future updates, wherever possible, we will carry out subgroup
analysis to account for differences in the primary outcome of RTW
and disability rates between:
• gender, i.e. men versus women;
• different stages of the disease, e.g. clinically asymptomatic
(WHO stages 1 and 2) versus symptomatic including AIDS
(WHO stages 3 and 4);
• type of employment before diagnosis was made, e.g. health-
related versus non-health-related employment;
• economic setting, e.g. low income, lower middle income,
and upper middle income versus high income.
If we can conduct subgroup meta-analyses in future updates, we
will quantify the degree of heterogeneity using the I² statistic,
where an I² value of 30%to60% indicatesmoderate heterogeneity,
50% to 90% substantial heterogeneity, and greater than 75% con-
siderable heterogeneity (Higgins 2011. We will investigate sub-
stantial heterogeneity further using meta-regression assuming that
we have included an adequate number of studies.
Sensitivity analysis
In our protocol we planned to conduct a sensitivity analysis to
monitor the robustness of the results. However, our meta-analysis
only includes two studies. Therefore, we did not conduct a sensi-
tivity analysis.
R E S U L T S
Description of studies
Results of the search
We searched six key databases up toDecember 2014: theCochrane
Central Register of Controlled Trials (CENTRAL), MEDLINE,
EMBASE, CINAHL, PsycINFO, and OSH Update (CISDOC,
HSELINE, NIOSHTIC, NIOSHTIC 2, RILOSH). The intial
search in 2012 yielded a total of 5799 studies. After removal of
duplicate references, 4787 studies remained. In June 2013 and
December 2014 we conducted update searches of all the afore-
mentioned databases, resulting in an additional 460 and 331 ref-
erences, respectively. We obtained a combined total of 5578 ref-
erences for title and abstract inspection.
Evaluation of the reference titles and abstracts identified 29 studies
for full-text examination. Nine studies did not meet the study de-
sign criteria of RCT or CBA studies. We disqualified two studies
due to topic irrelevance. We excluded an additional five studies
due to lack of a control group. We eliminated one final study that
focused on chronic diseases and RTW because HIV-specific out-
come datawas unavailable (we requested rawdata from the authors
but they could not provide HIV-specific data). Ten studies re-
mained for further consideration (Bor 2012; Baran 2012; Borwein
2010; Larson 2013; Linnemayr 2013; Martin 2012; Nannungi
2013; Paul-Ward 2005; Popiel 2010; Thirumurthy 2011). We
categorized four of these as ’Studies awaiting classification’ (see
Characteristics of studies awaiting classification); three due to a
lack of full-text article and one because it was in progress in 2005,
but we could not locate a final publication of outcome data. We
requested full-text articles from the authors of these studies as well
as unpublished raw outcome data, but we received none. The re-
maining six studies (one RCT and five CBA studies) formed the
list of the final six included studies on which we performed data
extraction and ’Risk of bias’ assessment (Bor 2012; Larson 2013;
Linnemayr 2013; Martin 2012; Nannungi 2013; Thirumurthy
2011). See Figure 1 for the PRISMA study flow diagram.
Included studies
See Characteristics of included studies.
Study designs
We found one RCT (Martin 2012) and five CBA studies
(Bor 2012; Larson 2013; Linnemayr 2013; Nannungi 2013;
Thirumurthy 2011). The RCT utilized a stratified randomization
procedure; the researchers stratified participants in both control
and index groups on education, CD4 count, and ethnic minor-
ity status to account for potential influence of these covariates.
All five CBA studies were ART studies (Bor 2012; Larson 2013;
Linnemayr 2013; Nannungi 2013; Thirumurthy 2011). Both
Larson 2013 and Bor 2012 were retrospective analyses of cohorts.
Whereas Linnemayr 2013, Nannungi 2013, and Thirumurthy
2011 were prospective cohort studies.
Number of participants
Martin 2012 studied 174 HIV+ persons comprising of 83 index
participants and 91 references. Bor 2012, Larson 2013, Linnemayr
2013, Nannungi 2013, and Thirumurthy 2011 studied a total of
3336 index participants and 44,722 references.
Types of participants
The vocational therapy RCT conducted by Martin 2012 re-
cruited participants through advertisements at AIDS service or-
ganizations, community and mental health centers, HIV medical
providers, gay and lesbian centers, community forums for HIV-
positive adults, and through advertisements in publications tar-
geted at HIV+ persons in the United States.
Two studies analyzed HIV+ workers referenced against the non-
HIV general work force (Bor 2012; Larson 2013). Larson 2013
11Interventions for improving employment outcomes for workers with HIV (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
examined a cohort of tea pluckers in two major Kenyan tea plan-
tations. Bor 2012 used data from all inhabitants of Hlabisa sub-
district in South Africa and combined employment data extracted
from the Africa Centre for Health and Population Studies surveil-
lance system with data on being HIV+ from the Hlabisa HIV
Treatment and Care Program records.
Three studies compared HIV+ persons on ART to HIV+ per-
sons not yet eligible for ART (Linnemayr 2013; Nannungi 2013;
Thirumurthy 2011). Linnemayr 2013 and Nannungi 2013 ex-
amined participants from four Ugandan HIV treatment clin-
ics, one rural (Kakira) and three urban (Kampala). Thirumurthy
2011 compared HIV+ persons who had initiated ARTwith HIV+
persons who were classified as pre-ART and were a part of the
TamilNaduFamilyCareContinuum (TNFCC)Program inTamil
Nadu, India. In all five CBA studies, participants were of working
age (16 years or older) and wereHIV+. Additionally, Thirumurthy
2011 also included 67 children in their analysis as well as 54 care-
takers.
Interventions
The included studies evaluated five pharmacological ART inter-
ventions and one mixed vocational and psychological interven-
tion (Bor 2012; Larson 2013; Linnemayr 2013; Martin 2012;
Nannungi 2013; Thirumurthy 2011).We found no psychological
interventions. The vocational intervention consisted of 13 group
sessions with at least 1 individual session, carried out over a 7-
week period (Martin 2012). The group sessions included presen-
tations, brainstorming, discussions, role playing, and homework
assignments regarding motivation and barriers to RTW, concerns
of a HIV+ persons in the work force, skills for retaining a job, and
“thinking like an employer” training.
The pharmacological intervention CBAs consisted of measuring
employment outcomes prior to ART initiation, at the time of ART
initiation, and at several follow-up intervals (Bor 2012; Larson
2013;Linnemayr 2013; Nannungi 2013; Thirumurthy 2011).
HIV+persons in the Larson 2013 study received free ART through
their workplace hospitals and clinics. Participants in the Bor 2012
study received free ART from the Hlabisa HIV Treatment and
Care Program. In the Linnemayr 2013 study, participants received
basic HIV primary medical care and ART from two Joint Clin-
ical Research Centre HIV clinics in Uganda, one rural (Kakira)
and one urban (Kampala). The participants in Nannungi 2013
acquired HIV primary medical care and ART from two HIV clin-
ics in urban Kampala, Uganda. Thirumurthy 2011 participants
received free ART from the TNFCC Program. Additionally, all
of the Thirumurthy 2011 participants received other clinical care
services, nutritional supplements, and home-based care, which for
the indexed participants involved ART adherence support.
Time period and location
All six included studies were conducted between 2000 and 2013.
The studies were conducted in South Africa, the United States,
India, Kenya, and Uganda.
Outcomes reported
RCT
The Martin 2012 study measured employment as any type of
employment in the past 6 months, job training class attendance,
and active job searching in the past 30 days.
Although Martin 2012 reported having measured employment
outcomes at 6, 12, 18, and 24 months post-ART initiation, but
the authors published only baseline data. We requested the 6-, 12-
, 18-, and 24-month follow-up outcome data from the authors,
but we did not receive a response.
CBA
Bor 2012 measured employment solely as employed versus un-
employed. Employment was measured 24, 18, 12, and 6 months
before beginning ART and 0, 6, 18, 24, and 30 to 60 months
following ART initiation. The authors reported the ORs from lo-
gistic regression with T-values. We calculated the standard error
needed for input into the data tables by dividing the logOR by
the reported T-value.
Larson 2013 measured employment as days worked in the past
month and stratified the results by gender. The researchers mea-
sured employment 24, 18, 12, and 6 months before beginning
ART and 0, 6, 18, 24, and 30 to 60 months following ART initi-
ation.
Linnemayr 2013 measured employment status based on whether
or not the HIV+ persons had participated in employment activity
in the week prior to the interview. The researchers measured em-
ployment for all participants at 0, 6, and 12 months and reported
as changes in employment status. The authors reported the ORs
from logistic regression with T-values. We calculated the standard
error needed for input into the data tables by dividing the logOR
by the reported T-value. The authors graphically reported 0, 6,
and 12 months outcomes for currently working, pain interference
with work, health interference with work, and work sel-efficacy.
We contacted the authors for the raw data of these outcomes but
we did not receive a response.
Nannungi 2013 measured employment status as a binary outcome
based on whether or not the HIV+ persons had participated in
employment activity in the week prior to the interview. The re-
searchers measured employment for all participants at 0, 6, and
12 months.
Thirumurthy 2011 measured employment as hours worked in
the last week and stratified the results by gender. The researchers
measured employment at 6, 12, 18, and 24 months following
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ART initiation. We contacted the authors for further explanation
of their Table 3 but we did not receive a response.
None of the included studies, whether RCT or CBA, measured
our secondary outcomes of quality of life or costs.
Excluded studies
We gave 19 studies particular consideration before exclusion as
detailed in the Characteristics of excluded studies section. We ex-
cluded nine of these studies on the basis of irrelevant study de-
sign, that is they were not RCTs or CBA intervention studies
(Bernell 2005; Martin 2003; Resch 2011; Rosen 2004; Rosolen
2002; Rueda 2012; Thirumurthy 2013; Van der Borght 2006;
Van der Borght 2010). Six studies did not have control groups
(Ajithkumar 2007; Escovitz 2005; Goldman 2004; Hergenrather
2013; Rosen 2010; Rosen 2014). We excluded one purely qual-
itative study (Maticka-Tyndale 2002). We excluded Herdt 1999
due to lack of topic relevance.We excluded Lee 2005 due to a lack
of specific HIV data. We also excluded a summary of an ongoing
study (Martin 2005) that was later published as Martin 2012.
Risk of bias in included studies
See Figure 2 for an overall view of our assessment of the included
studies’ risk of bias.
Figure 2. ’Risk of bias’ summary: review authors’ judgments about each ’Risk of bias’ item for each included
study.
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Allocation
RCT
The researchers of the RCT reported adequate details on their
randomization sequence generation (Martin 2012). However, we
judged their allocation concealment to be unclear. As the study
recruited participants from multiple AIDS service organizations,
community mental health centers, HIV medical providers, and
gay/lesbian centers, some participant features may be dispropor-
tionately represented in index and reference groups. However, re-
ported baseline demographics were similar between groups. We
therefore determined the risk of population selection bias as un-
clear. We found no evidence of time selection bias, as recruitment
of all participants occurred during the same time frame.
CBA
Prior analysis predetermined allocation to reference and control
groups in both retrospective cohort studies (Bor 2012; Larson
2013). The participants’ CD4 counts and health status preor-
dained allocation to index and reference groups in the prospective
studies (Linnemayr 2013; Nannungi 2013; Thirumurthy 2011).
All HIV+ persons utilizing ART (CD4 count less than 250 cells/
mm³) were assigned to the index group and all HIV+ persons pre-
ART (CD4 count less than 400 cells/mm³ but greater than 250
cells/mm³) were assigned to the control group. We considered the
risk of selection bias for the population as low in all five obser-
vational studies. Three studies’ use of HIV+ persons seeking care
for both the index and reference groups reduces selection bias by
eliminating the potential differences between people who choose
to seek care and those who choose not to seek care (Linnemayr
2013; Nannungi 2013; Thirumurthy 2011). Bor 2012 gathered
participants in both the index and reference groups from the Africa
Center forHealth and Population Studies’ population surveillance
system. Bor 2012 included all HIV+ people who were utilizing
ART during the 10-year follow-up period of the Africa Centre for
Health and Population Studies’s population surveillance study and
who sought care through the Hlabisa HIV Treatment and Care
Programme as index participants. Larson 2013 collected all par-
ticipants from the work forces of two Kenyan tea plantations. For
index participants, Larson 2013 used all HIV+ workers who vis-
ited the tea plantation hospitals and healthcare clinics. Linnemayr
2013 used clinic staff to approach eligible clients for study partic-
ipation at the appointment in which ART eligibility was assessed.
Nannungi 2013 enrolled consecutive new clinic clients who had
recently been evaluated for ART eligibility. Thirumurthy 2011
procured index and reference group participants from the Tamil
Nadu Family Care Continuum Program.
There was no randomization in any of the five studies, as all HIV+
persons who were utilizing ART were assigned to the index group
out of physical necessity. However, we judged the studies as at
low risk of selection bias, as all HIV+ persons using ART were
assigned to the index group. Recruitment of index and reference
participants occurred at the same time in all five observational
studies, showing no time-based selection bias.
Blinding
RCT
AsMartin 2012 did not report blinding of participants or outcome
assessors, we assessed the risk of bias due to blinding as high.
CBA
For two of the CBA studies, due to the retrospective comparisons
of HIV+ persons on ART versus healthy people, we considered
the participants to be blind to the idea of a special intervention,
as they were not aware of the study at the time (Bor 2012; Larson
2013). For the prospective HIV+ persons on ART versus HIV+
persons pre-ART comparison, Linnemayr 2013, Nannungi 2013,
and Thirumurthy 2011 did not blind participants, as health status
required knowledge of treatment. Nevertheless, due to the objec-
tive employment/unemployment outcome in all five CBA studies,
we believe the lack of blinding has not biased the results. Blind-
ing of the outcome assessors was unclear in all five CBA studies,
however we believe that this lack of assessor blinding did not bias
results due to objective administrative outcomes.
Incomplete outcome data
RCT
Martin 2012 did not report employment rates past the baseline
and did not address attrition and reasons for missing data. We
therefore assessed the risk of bias due to incomplete outcome data
as high.
CBA
All five of the non-randomized CBAs addressed attrition rates
of the index groups (Bor 2012; Larson 2013; Linnemayr 2013;
Nannungi 2013;Thirumurthy 2011). Larson 2013missed data on
6% of index participants due to death, resignation, or retirement.
Larson 2013 reported no attrition data on the control group.
Bor 2012 excluded data on 20% of index participants due to
attrition, mortality, late cohort entry, and lack of employment
information, but did not report attrition data for the reference
group. Linnemayr 2013 reported low attrition with approximately
95% retention of study participants and used an intention-to-treat
analysis. However, Nannungi 2013 reported 30% attrition at 6
months, which increased to 36% at 12 months. The high level
of attrition in Nannungi 2013 was evenly distributed between
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the ART and non-ART groups, at 37% and 35%, respectively.
Thirumurthy 2011 had an attrition of 34% and did not report
any outcome data for controls.
Due to a lack of reporting of attrition for the controls in three
studies (Bor 2012; Larson 2013; Thirumurthy 2011), we judged
the risk of bias to be high for incomplete outcome data.
Two studies reported no data for compliance to ART intervention
(Bor 2012; Larson 2013). Neither Linnemayr 2013 norNannungi
2013 measured compliance with ART. Thirumurthy 2011 pro-
vided ART adherence support but did not provide data for com-
pliance. However, in all five ART intervention studies (Bor 2012;
Larson 2013; Linnemayr 2013; Nannungi 2013; Thirumurthy
2011), we can reasonably assume that compliance to ART med-
ications would be high, as the health of the participant is highly
dependent upon adherence. Martin 2012 monitored compliance
and conducted a dose-response analysis, but insufficiently reported
the results and explanation.
We judged all five CBA studies to have an unclear risk of bias
for compliance with the intervention, due to a lack of reporting
of compliance measures combined wtih the necessity of ART for
survival, which may encourage intervention compliance.
Selective reporting
We judged Martin 2012 to have a high risk of reporting bias due
to complete lack of reporting of any follow-up outcome data.
All five CBA studies, Bor 2012, Larson 2013, Linnemayr 2013,
Nannungi 2013, and Thirumurthy 2011, reported all of the orig-
inal outcomes determined at the onset of the study for the index
groups.
The two retrospective observational studies conducted retro-
spective unplanned subgroup analysis (Bor 2012; Larson 2013),
whereas the single RCT is most likely guilty of data dredging due
to complete lack of outcome reporting and presenting results based
on complicated and unjustified statistical analysis (Martin 2012).
We determined that the three prospective CBA studies did not in-
dicate any unplanned retrospective subgroup analysis (Linnemayr
2013; Nannungi 2013; Thirumurthy 2011).
Other potential sources of bias
RCT
The single RCT did not report any co-occurring interventions
(Martin 2012). Also, the authors did not account for ART utiliza-
tion in the health status outcome, which could have influenced
the results. Hence, we judged Martin 2012 to have a high risk of
other bias.
CBA
Baseline comparability assessment of the index and reference
groups shows a high risk of bias for all five CBA studies (Bor 2012;
Larson 2013; Linnemayr 2013; Nannungi 2013; Thirumurthy
2011). As the studies inconsistently reported baseline characteris-
tics, it is unclear if the baseline characteristics were appropriately
comparable within comparisons. The baseline characteristics of
intervention participants presented in the Linnemayr 2013 study
showed significantly fewer are working, higher levels of pain in-
terfering with work, higher levels of health interfering with work,
lower levels of self efficacy, lower CD4 counts, lower levels of
primary education, higher rates of depression, and lower overall
physical function. The authors claim to have performed a sensi-
tivity analysis restricting the control group to those with a similar
health status as the intervention group, but for whom ART had
been deferred. The authors of the Linnemayr 2013 study alleged
that the results of the sensitivity analysis did not differ from the
intention-to-treat analysis, meaning that the differences in health
status at baseline did not affect the intervention effect. However,
they did not publish this data. The Nannungi 2013 study base-
line characteristics showed a higher percentage of controls work-
ing at baseline with better overall health. The beneficial outcome
reported may be confounded by the difference in disease severity
at baseline between the pre-ART participants and the participants
initiating ART. The health of HIV+ persons on ART may im-
prove over time, while pre-ART participants’ health may decline,
leading to an inflation of the intervention effect. The Linnemayr
2013 study avoided similar inflation of the intervention effect by
performing intention-to-treat analysis, keeping all participants in
their original groups regardless of ART status at end of follow-
up. However, the use of intention-to-treat analysis may have un-
dermined the overall effect of the intervention. Once again, the
authors of the Linnemayr 2013 study claim to have performed
a second sensitivity analysis that excluded all participants in the
control group who initiated ART during the study period. The
analysis supposedly resulted in similar findings to the intention-
to-treat analysis and therefore the authors did not provide the data
and the finding cannot be verified within the text.
We assigned a high risk of bias to three of the observational CBA
studies due to a lack of adjustment for confounding. Bor 2012 ad-
justed for migration but did not adjust for age, sex, socioeconomic
status, or disease severity. Larson 2013 adjusted for gender but
did not adjust for age, socioeconomic status, migration, or disease
severity. Thirumurthy 2011 adjusted for gender but did not adjust
for age, socioeconomic status, migration, or disease severity. We
deemed an unclear risk of bias for two of the prospective observa-
tional studies for adjustment for confounding, as they adjusted for
some but not all potential confounders. Linnemayr 2013 stratified
data by gender and urban/rural and included physical and men-
tal health confounders. Nannungi 2013 adjusted for changes in
physical health status, age, gender, education, relationship status,
and CD4 count.
None of the five CBA studies reported possible cointerventions
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that may have influenced the employment outcome.
Due to the file drawer phenomenon, bias often results in the pub-
lication of only positive-outcome studies. All studies included in
this review provided positive intervention effects, leading to a pos-
sible artificially augmented effect. However, in regards to the ART
intervention, the well-documented improvement in health status
due to ART supports the positive findings.
Overall risk of bias in included studies
RCT
We determined the overall risk of bias in the single included RCT
based on allocation concealment/randomization, blinding, loss to
follow-up, and selective reporting. We had decided a priori to
consider studies to have a low risk of bias if we graded all four
items as low.
The above criteria resulted in a judgment of high overall risk of
bias for Martin 2012. The study had an unclear risk of allocation
concealment and a high risk of bias due to a lack of blinding and
selective reporting.
CBA
We determined the overall risk of bias in the CBA studies based
on selection bias (items 21 and 22), adjustment for confounding
(25), and baseline comparability using the Downs 1998 checklist.
We disregarded randomization and allocation concealment, as by
definition the studies are non-randomized. We did not include
blinding of outcome assessors, participants, and providers because
the outcome is objectively obtained. We had decided a priori to
consider a CBA study to have a low overall risk of bias if we graded
all four items as low.
See Figure 2 for an overall view of our assessment of the included
studies’ risk of bias.
Bor 2012 had a high overall risk of bias. We judged the study to
have a low risk of selection bias, a high risk of bias associated with
adjustment for confounding, and a high risk of bias for baseline
comparability.
Larson 2013 had a high overall risk of bias. We judged the study
to have a low risk of selection bias, a high risk of bias due to a lack
of adjustment for confounding, and a high risk of bias for baseline
comparability.
Linnemayr 2013 had a high overall risk of bias. We judged the
study to have a high risk of population selection bias, an unclear
risk of time selection bias, an unclear risk of bias for adjustment
for confounding, and an unclear risk for baseline comparability.
Nannungi 2013 had a high overall risk of bias. We judged the
study to have a high risk of population selection bias, a low risk of
time selection bias, an unclear risk of bias due to adjustments for
confounding, and a high risk of bias for baseline comparability.
Thirumurthy 2011 also had a high overall risk of bias. We judged
the study to have a low risk of selection bias, a high risk of bias
due to adjustment for confounding, and an unclear risk of bias for
baseline comparability.
Effects of interventions
See: Summary of findings for the main comparison
I. Pharmacological interventions
A. HIV+ persons utilizing ART versus healthy (non-HIV+)
individuals
Two CBA studies compared the effect of ART interventions in
HIV+ persons on employment status to a control group of healthy,
untreated participants (Bor 2012; Larson 2013). Both studies used
existing data on health and employment outcomes before and after
ART initiation. Bor 2012 used retrospective data from a cohort
from the Hlabisa Treatment and Care Program surveillance area
in South Africa over 10 years. Larson 2013 drew data from hos-
pitals and employer records of two major Kenyan tea plantations.
The studies defined employment status as employed/unemployed
and as the number of days worked per month. As an employment
measure, the number of days worked highlights the ability of the
participant to maintain work in comparison to the healthy con-
trols.
We could not combine the results of these studies in meta-anal-
ysis due to the use of different outcome measures and statistical
methods within the studies.
Primary outcome: being employed
24 to 18 months before start of ART
Neither Bor 2012 or Larson 2013 found a statistically significant
difference between HIV+ persons and healthy participants in em-
ployment status. Bor 2012 found no difference in being employed
or not, OR 0.79 (95% CI 0.61 to 1.02; Analysis 1.1), whereas
Larson 2013 found no difference in number of days worked per
month, MD -0.05 days (95% CI -0.50 to 0.40; Analysis 1.2).
6 to 0 months before start of ART
Bor 2012 and Larson 2013 both found a significant decrease in
employment 6 months prior to the start of ART for HIV+ persons
in comparison to healthy participants in the work force. Bor 2012
reported the HIV+ person more likely to be unemployed, with an
OR of 0.50 (95% CI 0.26 to 0.47; Analysis 1.1). Similarly, Larson
2013 found HIV+ persons to have worked significantly less, with
a MD of -1.28 days (95% CI -1.65 to -0.91; Analysis 1.2).
At ART initiation
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At the time of ART initiation, both studies observed a continual
downward trend, with the lowest levels of employment for HIV+
participants. Bor 2012 found an OR 0.35 (95% CI 0.26 to 0.47),
meaning a three-fold lower rate of employment in the HIV+ par-
ticipants when compared to the healthy persons. The findings of
Larson 2013 were similar, with a MD of -8.49 (95% CI -9.57 to
-7.41), translating to an 8 to 9 days’ difference in days worked per
month between the index and reference groups.
6 months after ART initiation
Bor 2012 reported an OR of 0.38 (95% CI 0.28 to 0.52; Analysis
1.1), indicating that HIV+ persons were still less likely to be em-
ployed after 6 months on ART than the reference group.
However, in Larson 2013, the difference in employment between
healthy participants and HIV+ persons decreased immediately af-
ter the start of ART. Larson 2013 reported a MD of 0.08 days
(95% CI 0.05 to 0.11; Analysis 1.2), meaning that HIV+ persons
on ART had worked only slightly less than participants of the
healthy reference group.
18 to 24 months after ART initiation
Bor 2012 reported an OR of 0.44 (95% CI 0.31 to 0.62; Analysis
1.1), representing a significantly lower likelihood of being em-
ployed for HIV+ participants on ART when compared to the
healthy work force.
Larson 2013 reported a MD of -1.22 days (95% CI -1.74 to -
1.07; Analysis 1.2), meaning that the HIV+ persons had worked
a little less per month than the healthy workers in the reference
group.
36 to 60 months after ART initiation
Bor 2012 found similar employment rates in both groups, with
an OR of 0.73 (95% CI 0.42 to 1.28) at 36 to 60 months post-
ART initiation (Analysis 1.1).
Additionally, Bor 2012 measured “unemployment due to illness”,
“job loss spells”, and “resides in surveillance area”; we did not in-
clude these figures in our review due to their reciprocal nature to
the employment outcomes measured above (Analysis 1.3; Analysis
1.4). We made this decision to prevent double counting of out-
comes. TheOR of 2.17 (95%CI 1.31 to 3.58) for unemployment
due to illness at ART initiation declines to 0.70 (95% CI 0.32 to
1.55) by 18 to 24 months post-ART.
B. HIV+ persons utilizing ART versus HIV+ persons pre-ART
We found three CBA studies (2748 participants) comparingHIV+
persons on ART with HIV+ persons pre-ART.
Thirumurthy 2011 measured RTW by the number of hours
worked in the past week. The study obtained follow-up data every
6 months, culminating at 24 months post-ART initiation. The
authors used linear regression analysis and a dummy coding sys-
tem that coded for either all workers at different follow-up or for
those on ART only at follow-up. Thus the results are expressed as
the number of hours that the group on ART worked more than
the average cohort. Some of the participants got ART in between
follow-up. The authors excluded these participants from the anal-
ysis.
Nannungi 2013 and Linnemayr 2013 measured RTW as a bi-
nary ’yes’ or ’no’ outcome, by whether or not the participant en-
gaged in work activities in the last seven days prior to the inter-
view. Nannungi 2013 reported percentages of participants who
had RTW who were not employed at baseline as a change in work
status at 6 and 12 months. Linnemayr 2013 reported the data
graphically; we could not obtain raw data for this review. In future
updates of this review, we will present the outcomes for partici-
pants currently working at baseline (0 months), 6 months, and 12
months, if we are able to obtain the raw data at that time. Addi-
tionally, Nannungi et al and Linnemayr et al also document the
impact of ART over time.
Primary outcome: RTW
6 months after ART initiation
Participants who initiatedARTworked 11.95 hours (95%CI 6.75
to 17.15) more per week than the average of the HIV+ cohort of
ART and pre-ART persons, which was 3.7 hours (Analysis 2.2,
Thirumurthy 2011).
Nannungi 2013 reported that of those on ART not working at
baseline (n = 88), 50.9% returned to work (n = 45). Of the pre-
ART group unemployed at baseline (n = 57), 48.8% were at work
at 6 months (n = 28).
Of those on ART working at baseline (n = 169), 81.4% were still
working at 6 months (n = 138) . In the pre-ART group, of those
working at baseline (n = 168), 84.5% were still employed at 6
months (n = 142) (P value = 0.000). Overall, 53% of those on
ART (n = 136) were working compared to 47% of those in the
pre-ART group (n = 106) at 6 months. However, the pre-ART
group had more favorable predictive factors.
12 to 24 months after ART initiation
Long-term follow-up indicated a 12.1-hour (95% CI 6.99 to
17.21) increase in hours worked per week at the end of 24 months
for the baseline ART group compared to the average of the cohort
which was 21 hours (Analysis 2.2, Thirumurthy 2011).
Nannungi 2013 reported continued improvement in employment
status at 12 months after ART intitiation; of those on ART and
not working at baseline (n = 88), 55.6% had returned to work
(n = 49). Of those in the pre-ART group unemployed at baseline
(n = 57), 50.0% had RTW at 12 months (n = 29). However, the
pre-ART group had strong predictive characteristics for regaining
employment compared to ART group.
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Of those on ART working at baseline (n = 169), 87.7% were still
working at 12 months (n = 148) . In the pre-ART group, of the
74.5% working at baseline (n = 168), 75% were still employed at
12 months (n = 126).
Overall, 46% of those on ART (n = 118) were working compared
to 54% of those in the pre-ART group (n = 121) at 12 months.
However, the pre-ART group had more males, better physical
health functioning and higherCD4 count, which are the strongest
predictors of employment. After adjusting for gender, age, physical
health functioning, education, relationship status andCD4 count,
the ART group was more likely to be employed than the pre-ART
group (OR 1.56, 95% CI 1.15 to 2.12) at 12 months folllow up.
Linnemayr 2013 found a greater likelihood of employment for the
ART group compared to the pre-ART group (OR 1.88, 95% CI
1.47 to 2.41) at 12 months follow-up.
Themeta-analysis for Linnemayr 2013 andNannungi 2013 found
an increased likelihood of employment for those on ART (OR
1.75, 95% CI 1.44 to 2.12) Analysis 2.1.
II. Vocational interventions
Vocational therapy versus no vocational therapy
Primary outcome: RTW
Martin 2012 measured outcomes at 6-month intervals beginning
at baseline and continuing at 6, 12, 18, and 24 months, however
the authors did not report these follow-up results, only providing
a table of “estimated transition rates” in and out of employment
based on a Markov model for the outcomes. We requested further
information, but the authors did not provide it.
Grading of the evidence
We used the GRADE approach to assess the quality of the evi-
dence. All three observational studies, that is Bor 2012, Larson
2013, and Thirumurthy 2011, started with a low-quality evidence
rating, and the RCT, that is Martin 2012, began at high rating as
prescribed by the GRADE approach protocol (see Table 1).
HIV+ persons utilizing ART versus healthy participants
We rated the evidence in this comparison to be very low quality.
We downgraded the quality of evidence based on a high risk of
bias due to limitations in study design and implementation. We
did not downgrade the quality of the evidence due to indirectness
because we judged there to be no limitations due to the use of
direct populations, comparable interventions with similar control
groups, and no use of surrogate data. Unexplained heterogeneity
or inconsistency in the results showed no limitations for further
downgrading of the evidence. We downgraded the quality of the
evidence further based on imprecision, which was due to wide
confidence intervals in both studies. We did not find evidence to
downgrade for publication bias.
We found no justification for upgrading the quality of evidence.
The magnitude of effect was not large, there was no dose-effect
relation, and the studies did not exclude all confounding.
HIV+ persons utilizing ART versus HIV+ persons pre-ART
We graded the quality of evidence for this comparison as very
low. We found no reason to downgrade the quality of evidence
because of problems in allocation concealment and blinding. We
downgraded the quality of evidence for limitations in study design
implementation due risk of bias for baseline comparability, lack
of adjustment for confounding and incomplete attrition data. We
did not find any reason to downgrade for the indirectness of the
evidence in this comparison. We found no sign of indirect evi-
dence or use of surrogate data in any study. There was no reason to
downgrade the quality of the evidence based on unexplained het-
erogeneity or inconsistency in the results or for publication bias.
We found no justification for upgrading the quality of evidence.
The magnitude of effect was not large, there was no dose-effect
relation, and the studies did not exclude all confounding.
Vocational therapy versus no vocational therapy
We graded the quality of evidence for this comparison as very low.
We downgraded the quality of evidence based on limitations in
study design and implementation, as the study had a high risk of
bias due to a lack of reporting of allocation concealment and loss
to follow-up. Furthermore, the study was unblinded and the use
of selective reporting necessitated another downgrade of the qual-
ity of evidence. We also downgraded the quality of the evidence
for indirectness of the evidence. The authors did not report any
follow-up data. As only a single study provided evidence for this
comparison, there was no need to downgrade the quality of the
evidence because of unexplained heterogeneity or inconsistency in
the results or because of publication bias. However, imprecision of
the results in the form of complicated, unjustified statistical anal-
ysis of unclear outcomes necessitated downgrading the quality of
the evidence further.
D I S C U S S I O N
Summary of main results
We found very low-quality evidence in five studies that ART for
HIV+persons improves ability towork andmaintain employment.
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Themagnitude of the intervention effect is unclear due to different
results between comparisons (HIV+ vs. Healthy; HIV+ on ART
vs. HIV+ pre-ART). The studies indicated that ART does not
fully restore work capacity in HIV+ persons compared to healthy
individuals. Two years after the start of ART, HIV+ persons still
worked fewer days than healthy people. Five years after the start of
ART there was a 27% greater unemployment rate among HIV+
people. However, the studies comparing HIV+ persons on ART
with HIV+ persons not yet on ART, indicate that ART receipents
are almost twice as likely to be employed than HIV+ persons pre-
ART.
Based on two studies conducted with 33,379 participants (Bor
2012; Larson 2013), we found very low-quality evidence show-
ing that HIV+ people utilizing ART worked less prior to ART
initiation and got increasingly employed after ART initiation. Al-
though employment increased after ART initiation, neither study
showed full recovery of employment for the HIV+ index group in
comparison to the healthy reference group during the follow-up
period.
Two studies showed a similar trend in outcomes over a four-year
period (Bor 2012; Larson 2013). There was no statistical differ-
ence at 24 months pre-ART initiation between the HIV+ persons’
index group and the healthy participants’ control group. However,
for the HIV+ persons, likelihood of employment and number of
days worked per month declined significantly by six months prior
to the start of ART. At the start of ART, unemployment in HIV+
persons was high in comparison to the healthy reference group.
Larson 2013 reported that employment outcomes improved six
months after ART initiation and continued to increase at 18 to
24 months after the start of ART. Although there was improve-
ment, neither Bor 2012 nor Larson 2013 indicated a full recov-
ery of employment outcomes by the HIV+ persons on ART. The
rate of improvement varied between the two studies. At 18 to 24
months post-ART initiation, Larson 2013 reported that HIV+
persons worked approximately one day less than healthy partic-
ipants. However, at 18 to 24 months post-ART initiation, Bor
2012 reported a likelihood of employment for HIV+ persons on
ART as less than half that of the healthy reference group. Bor
2012 reported statistically significant differences between the em-
ployment outcomes of the index group and those of the reference
group until 36 to 60 months post-ART initiation. The differences
between the results of the two studies can be partially accounted
for by their use of different outcome measures. The Larson 2013
study used number of days worked, which notes smaller improve-
ments in labor outcomes, whereas the Bor 2012 study used ab-
solute outcomes of employed/unemployed, which prevented the
intervention from showing smaller increases in labor productivity.
Linnemayr 2013 and Nannungi 2013 both reported improved
RTW outcomes in HIV+ persons on ART in Uganda over a 12-
month period. At baseline, the ART group had higher unemploy-
ment than the pre-ART group. Both studies indicated the most
significant improvement in employment outcomes in the first 6
months for HIV+ persons on ART. Similiar to the findings of Bor
2012 and Larson 2013,the number of those employed continued
to rise after 12 months on ART, although not as dramatically as in
the first 6 months. Half of those who were unemployed at baseline
returned to work at six months in both the ART and pre-ART
groups in one study (Nannungi 2013). Although, it is important
to note that the characteristics of the pre-ART group were more
favorable to employment, due to a higher number of males and
better overall health. Thereby, underestimating the overall effect
of the intervention. When the analysis was adjusted for gender and
health status, the likelihood of being employed favored the ART
group. Of those who were employed at baseline, a larger percent-
age of the ART group remained employed at 12 months follow-up
than in the pre-ART group. The meta-analysis indicated a higher
likelihood of employment in the ART group when considering
the impact of ART over time (Linnemayr 2013; Nannungi 2013).
Thirumurthy 2011 measured employment outcomes in hours
worked per week, indicating improvement in employment out-
comes after ART initiation over HIV+ people who were pre-ART.
The results indicate an intervention effect for ART improving the
number of hours worked per week. In the analysis, the combined
group of those on ART and those pre-ART worked an average of
21 hours per week, where the ART group alone worked approxi-
mately 32 hours per week up to 24 months follow-up.
From theBor 2012 andLarson 2013 studies, we know thatwithout
ART, unemployment rises considerably. Apart fromART, no other
factors have been identified within the literature to support the
increased labor productivity findings and employment outcomes
of Linnemayr 2013, Nannungi 2013, and Thirumurthy 2011.
Martin 2012 found no evidence of the effectiveness of vocational
rehabilitation interventions. As our systematic search yielded no
studies on psychological interventions, we cannot say if they help
or not.
Overall completeness and applicability of
evidence
The importance of interventions to help HIV+ persons to return
to work has been highly stressed. However, surprisingly few inter-
vention studies have been conducted in this area.
The studies we found had been conducted in countries with a high
prevalence ofHIV, that is SouthAfrica, Kenya, andUganda, aswell
as in countries with a lower prevalence of HIV, that is India and the
United States. There were no studies from Europe, Latin America,
or Australia. Given the differences in social security legislation, it
is unclear if the evidence applies to European countries.
Furthermore, evidence from one study suggested that ART inter-
ventions conducted in rural settings show a stronger effect. This
might be due to accessibility of employment for farmers who are
self-employed or working in the informal sector, whereas urban
participants may have greater difficulty reaccessing previous em-
ployment, particularly in areas with higher formal-sector devel-
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opment (Linnemayr 2013). Of the five included pharmacological
studies, only one study, Linnemayr 2013, identified rural partic-
ipants from urban participants and analyzed the data separately.
Two other studies identified mixed urban and rural residency
among participant demographics, but did not perform subgroup
analysis on the data (Bor 2012; Rosen 2010).Nannungi 2013 used
data from urban clinics. Larson 2013 focused exclusively on tea
plantation workers and therefore must be considered separately,
as all the participants worked for the same employer. The lack of
subgroup analysis between rural and urban groups hindered ap-
plicability of the evidence across different socioeconomic and geo-
graphical locations. Part and parcel of the rural versus urban issue,
the nature of employment - that is, whether formal or informal - is
not consistently distinguished throughout the studies, which may
also contribute to a lack of applicability of the evidence by not
providing a full picture of the effect of ART on different careers
and their RTW outcomes.
Research suggests that women are at higher risk of unemploy-
ment overall than men. Dray-Spira 2006 highlighted the dispro-
portionate loss of employment for women. In this review, only the
study by Thirumurthy 2011 supports this finding. Three studies
stratified outcome data by gender (Larson 2013; Linnemayr 2013;
Thirumurthy 2011); however, the studies yielded conflicting re-
sults and were unable to fully account for the differences between
sexes. Larson 2013 and Linnemayr 2013 reported potentially bet-
ter employment outcomes for women. Larson 2013 suggested that
women’s improved employment outcomes could be due to the in-
creased likelihood of transfer to less physically demanding work.
However, the statistically nonsignificant findings for males in the
Linnemayr 2013 study could be due to the small male sample
size and therefore insufficent power to detect the actual effect.
In contrast, Thirumurthy 2011 reported better employment out-
comes for males. Thirumurthy 2011 hypothesized that discrimi-
nation among the sexes segregates employment opportunities in
theKwaZulu-NatalUmkhanyakudeDistrict, and these differences
could play a role in HIV+ peoples’ ability to maintain or return
to employment. Therefore, the gender component of RTW out-
comes needs further exploration. Interventions need to be tailored
to suit the needs of each sex, confounding for different societal,
cultural, economic, and physical factors specific to each gender
within a specified population. The lack of these adjustments may
diminish the confidence in the intervention effect.
Unfortunately, we could not include all potentially relevant stud-
ies in this review. Baran 2012 examined multiple ART therapies
in relation to healthcare costs and economic productivity for em-
ployers. This data could contribute to understanding the cost-ef-
fectiveness of ART programs as a secondary outcome. However,
AbbVie Pharmaceutical Group funded the study and would not
approve the release of necessary unpublished data for our use.
The study examined three different types of ART medications,
highlighting the differences in outcomes for participants based on
the specific ART medication combination they received (Baran
2012). None of the pharmacological interventions in this review
accounted for differences in medication combinations. Had re-
searchers of the ART studies conducted subgroup analysis, inter-
vention effects could have been associated with specific treatment
regimens. Although theHIV+ participants were drawn from a sin-
gle geographic area or treatment center where a specific ARTmed-
ication combinationmay bemost common, there is no evidence to
indicate that participants received the same ARTmedication com-
binations or regimens. Therefore, research in regards to specific
ART medication combinations, such as in the Baran 2012 study,
could have shown differences in employment outcomes based on
different ARTmedication combinations. In addition, we excluded
a non-intervention, modeling study that examined the secondary
outcome of cost-effectiveness of ART programs by comparing es-
timated total program costs with select economic benefits of ART.
This study by Resch 2011 examined 1. restored labor productivity
among workers with AIDS, 2. orphan care expenditures avoided
because of parent survival due to ART, and 3. delayed end-of-
life care costs associated with AIDS-related death. Resch 2011 re-
ported an estimated expenditure of USD 14.2 billion for ART
from 2011 to 2020 for the South African cohort of 3.5 million
people. The study estimated a return on investment of USD 12
billion to USD 34 billion through improved labor productivity,
averted orphan care expenses, and deferred medical treatment for
end-of-life care and opportunistic infections.
One other prospective cohort study, that produced three-year and
five-year follow-up publications, Rosen 2010 and Rosen 2014, ex-
amined the economic well-being of ART patients in South Africa.
We excluded the study as it did not meet our inclusion criteria
due to the lack of a control group. However, the findings showed
a continued increase in employment from 32% to 44% between
the start of ART and the five-year follow-up. These findings sup-
port the findings in all five included CBA ART studies (Bor 2012;
Larson 2013; Linnemayr 2013; Nannungi 2013; Thirumurthy
2011). Of the 248 participants who were unemployed but looking
for work at baseline, 39% (n = 96) RTW, and of the 96 participants
who were unemployed at baseline and not seeking work, 30% (n =
29) RTW and 53% (n = 51) were actively seeking employment at
the end of follow-up. Furthermore, the study examined outcomes
outside of our predetermined outcomes, including the probability
of experiencing pain or fatigue in the last week, the probability
of being able to perform normal activities over the previous five-
day work week, and reliance on external support in the form of a
caretaker. The data collected demonstrated a decrease in reporting
pain in the previous week from 69% at baseline to 17% (P value
less than 0.001) and a decrease in reporting fatigue in the previous
week from 62% at baseline to 7% (P value less than 0.001) after
five years. These health improvements coincide with findings by
Larson 2013, where the measure of number of days worked al-
lowed for smaller improvements in labor outcomes to be noted.
Therefore, reductions in pain and fatigue due to ART may incre-
mentally improve a person’s capacity to work.
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The three includedART studies examined strict dichotomous out-
comes of employment or unemployment (Bor 2012; Linnemayr
2013; Nannungi 2013), whereas the other two ART studies exam-
ined reduction in the labor productivity of HIV+ persons without
a definitive loss of employment or re-employment (Larson 2013;
Thirumurthy 2011). The overall evidence did not account for spe-
cific reasons of unemployment but assumes loss of employment
is solely attributable to HIV status. Therefore, a pharmacological
intervention targeting loss of employment due to HIV would not
produce the same effect on RTWoutcomes forHIV+ persons who
lost their job for other reasons.
Two included studies evaluated the effects of CD4 counts or pro-
gression of the disease at initiation of the intervention (Linnemayr
2013; Nannungi 2013). Although the index group criteria in the
Thirumurthy 2011 study required participants to a have a CD4
count less than 200, the analysis did not take into account varying
levels of health status. Along the same vein, not all of the stud-
ies clearly distinguished HIV+ participants from participants with
fully developed AIDS. Only two studies clearly indicated the use
of World Health Organization (WHO) guidelines for diagnosis
of HIV/AIDS and ART eligibility (Linnemayr 2013; Nannungi
2013). The differing levels of health status, by either CD4 counts
orHIV versus AIDS, at initiation of the intervention could impact
the outcomes.
In 2012, the WHO reported varying levels of HIV prevalence
in working-age populations (15 to 49 years) among the coun-
tries examined in the pharmacological ART intervention studies:
South Africa (17.9%), Kenya (6.1%), Uganda (7.4%), and In-
dia (0.3%) (WHO 2013a; WHO 2013b; WHO 2013c; WHO
2013d). Within these countries, the overall makeup of the HIV+
population varies. These statistics indicate diverse social and po-
litical environments for HIV within each population. ART cov-
erage among HIV+ persons also varies between countries: South
Africa (80%), Kenya (73%), Uganda (64%), and India (50%).
Therefore, the ART environment, available knowledge, access to
other HIV services, and individual perceptions may also influence
employment outcomes within a specific population. The cultural,
social, educational, political, and economic diversity of each of
the countries included in this review should be considered when
examining the effectiveness of the interventions by their location.
Furthermore, none of the studies controlled for possible co-oc-
curring interventions, which may have positively altered the in-
tervention effect.
Quality of the evidence
Pharmacological interventions
HIV+ persons utilizing ART versus healthy (non-HIV+)
individuals
We rated the evidence in this comparison that includes two studies
(Bor 2012; Larson 2013) to be very low quality. We downgraded
the quality of evidence based on a high risk of bias due to limi-
tations in study design and implementation. We did not down-
grade the quality of the evidence due to indirectness because we
judged there to be no limitations due to the use of direct popula-
tions, comparable interventions with similar control groups, and
no use of surrogate data. Unexplained heterogeneity or inconsis-
tency in the results showed no limitations for further downgrad-
ing of the evidence. We downgraded the quality of the evidence
further based on imprecision, which was due to wide confidence
intervals in both studies. We did not find evidence to downgrade
for publication bias.
We found no justification for upgrading the quality of evidence.
The magnitude of effect was not large, there was no dose-effect
relation, and the studies did not exclude all confounding.
HIV+ persons utilizing ART versus HIV+ persons pre-ART
Wegraded the quality of evidence for this comparison that includes
three studies (Linnemayr 2013; Nannungi 2013; Thirumurthy
2011) as very low. We found no reason to downgrade the quality
of evidence because of problems in allocation concealment and
blinding. We downgraded the quality of evidence for limitations
in study design implementation due risk of bias for baseline com-
parability, lack of adjustment for confounding and incomplete at-
trition data. We did not find any reason to downgrade for the
indirectness of the evidence in this comparison. We found no sign
of indirect evidence or use of surrogate data in any study. There
was no reason to downgrade the quality of the evidence based on
unexplained heterogeneity or inconsistency in the results or for
publication bias.
We found no justification for upgrading the quality of evidence.
The magnitude of effect was not large, there was no dose-effect
relation, and the studies did not exclude all confounding.
Vocational interventions
HIV+ persons utilizing vocational therapy versus HIV+
persons not utilizing vocational therapy
We graded the quality of evidence for this comparison that in-
cludes just one study (Martin 2012) as very low. We downgraded
the quality of evidence based on limitations in study design and
implementation, as the study had a high risk of bias due to a lack
of reporting of allocation concealment and loss to follow-up. Fur-
thermore, the study was unblinded and the use of selective report-
ing necessitated another downgrade of the quality of evidence.We
also downgraded the quality of the evidence for indirectness of the
evidence. The authors did not report any follow-up data. As only
a single study provided evidence for this comparison, there was no
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need to downgrade the quality of the evidence because of unex-
plained heterogeneity or inconsistency in the results or because of
publication bias. However, imprecision of the results in the form
of complicated, unjustified statistical analysis of unclear outcomes
necessitated downgrading the quality of the evidence further.
Potential biases in the review process
We allowed the inclusion of studies with unemployed participants
at time of intervention initiation (Bor 2012; Linnemayr 2013;
Nannungi 2013; Thirumurthy 2011), which required relaxing our
predetermined inclusion criteria. This decision may have poten-
tially influenced the results.
Language bias is not a problem in this review, as we excluded no
studies on the basis of publication language.
Agreements and disagreements with other
studies or reviews
To our knowledge, this is the first systematic review to analyze
the effects of interventions designed to improve employment out-
comes for HIV+ persons.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
We found very low-quality evidence for an increase in days worked
and employment rates among HIV+ people who where started
on ART compared to healthy people to a level only a little under
that of healthy workers. Additionally, we found very low-quality
evidence for improvement in RTW outcomes for HIV+ persons
on ART compared to HIV+ persons who are pre-ART. There was
no evidence of the effectiveness of vocational rehabilitation. No
studies assessed the effectiveness of psychological or other inter-
ventions.
Implications for research
Further research is required and should include more RCTs of
vocational, psychological, educational, and support interventions.
Researchers should account for all possible influences on em-
ployment outcomes, such as co-occurring interventions available
within a treatment population. To improve the quality of the evi-
dence, studies should fully report predetermined outcomes as well
as account and compensate for attrition. All possible confounders
(gender, age, socioeconomic status,migration, anddisease severity)
should be analyzed. Researchers should focus specifically on dif-
ferences in employment outcomes by gender to help fine-tune the
potency of interventions. Future pharmacological studies should
clarify ART therapy regimens and differentiate between cART
(combination antiretroviral therapy) prescriptions.
RCTs
More RCTs would improve the quality of evidence. Although the
RCT study design is ideal for showing effectiveness, it is an uneth-
ical approach to conducting pharmacological ART interventions.
However, RCTs can be effectively utilized for vocational and psy-
chological interventions. Given the probably modest effect sizes
and a large risk of confounding, RCTs with a follow-up of at least
one year would be ideal.
CBA studies
CBA studies present a solution to the problem of studying ART
interventions. Future studies should aim to overcome the risk of
bias issues we identified in the studies we included in this review.
Blinding
All future studies should ensure blinding of outcome assessors,
even if blinding of participants and personnel is not possible.
Other interventions
Although our comprehensive search criteria yielded only five phar-
macological ART interventions and onemixed vocational and psy-
chological counseling intervention, many other intervention pos-
sibilities exist. For example, income support interventions could
possibly reduce the stress related to financial burden. Financial se-
curity may improve well-being and quality of life, whereas stress
may potentially lead to expedited disease progression followed by
job loss. Researchers could explore job or career field-specific in-
tervention programs that focus on meeting the specific needs of
the employee within the given profession. It is reasonable to as-
sume that involvement in meaningful work improves one’s sense
of self worth in addition to providing many other benefits. Care-
taker or family educational interventions might encourage RTW
by dispelling the myth that HIV+ people should not work and
must play the ’sick role’. Educational interventions for caretakers
or family could furthermore enhance the support system of the
HIV+ individual, thereby boosting RTW outcomes. Educational
interventions for employers could assist companies in mindfully
accommodatingHIV+employees, retainingHIV+employees, and
decreasing absenteeism. The aforementioned list is not exhaustive
of potential interventions, but merely highlights the most obvious
gaps in current knowledge.
Reporting
All of the studies in our review indicated a high risk of bias due to
incomplete outcome data and selective reporting. Future studies
should employ all appropriate methods to reduce risk of bias,
thereby improving the quality of evidence.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bor 2012
Methods CBA study (retrospective)
Participants 32,321 population cohort of all working-age (18-59) people who were members of a
household in Africa Centre for Health and Population Studies’s population surveillance
area during the 10-year follow-up period, excluding HIV+ persons not accessing ART.
(South Africa)
Index group: 2027 HIV+ persons
Reference group: 30,294
Interventions Intervention: Pharmacological, ART through the Hlabisa HIV Treatment and Care
Program
Control: Drawn from the same population, but non-HIV, untreated, apparently healthy
Outcomes Employment: Employment status measured as ’yes’ or ’no’
Authors also assessed:
1) Unemployment due to illness, 2) Residence in surveillance area (migration indicator)
, 3) Physical function: Walk 5 km without stopping, carry heavy objects for 20 meters
without stopping, participate in vigorous activities, 4) Immunological status: CD4+
lymphocyte counts
Notes ART
Risk of bias
Bias Authors’ judgement Support for judgement
14. Blinding (Subjects) Low risk Retrospective data collected and cross-referenced from a
cohort’s surveys of sociodemographics and health data. Par-
ticipants were unaware they were under investigation for
the specific intervention at the time of the cohort surveys
15. Blinding (outcome assessors) Low risk Not blinded. Retrospective data collected and cross-refer-
enced from a cohort’s surveys of sociodemographics and
health data. Objective outcomes that should have been un-
affected by blinding
16. Retrospective unplanned subgroup
analysis
Unclear risk Retrospective study, data dredging not clear.
17. Follow-up Low risk Follow-ups conducted for both index and reference at 8-5
years, 5-3 years, 3-2.5 years, 2.5-2 years, 2-1.5 years, 1.5-1
years, 1-0.5 year both pre- and post-ART initiation
18. Statistical tests Low risk Odds ratio, t-statistics, and hazards ratio
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Bor 2012 (Continued)
19. Compliance Unclear risk Compliance to ART was not monitored or insured. ART
adherence is required for survival, therefore compliance is
highly likely
20. Outcome measures Low risk All predetermined outcome measures were analyzed and
reported
21. Selection Bias (population) Low risk All participants were collected from South Africa’s Africa
Centre population surveillance area in the Hlabisa subdis-
trict. The study used all HIV+ persons who were utiliz-
ing ART during the 10-year follow-up period of the Africa
Centre’s population surveillance study
22. Selection bias (time) Low risk All individuals residing in the surveillance area were mon-
itored between 2001-2010 and for inclusion in the study
were required to have lived in the surveillance area 6months
prior to the establishment of the Hlabisa HIV Treatment
and Care Program
23. Randomization High risk No randomization. Retrospective cohort study.
24. Allocation concealment Unclear risk Retrospective study of a cohort. Participants were not as-
signed by the research team, but were predetermined by
health status. Did not report the use of adequate sequence
generation or allocation concealment techniques
25. Adjustment for confounding High risk Migration confounder addressed. Gender differences not
addressed. Age differences not addressed. SES differences
not addressed. Disease severity not addressed
26. Incomplete outcome data High risk 20.4%attrition in index group addressed.Nodata reported
for control group
Baseline comparability High risk Differences in gender proportions: Index group 80.1% fe-
male and reference group 59.9% female
Age groups were disproportionate: (18-25 years) index 17.
5%, reference 49.4%; (25-34 years) index 38.7%, reference
21%; (35-44 years) index 31%, reference 18.2%
SES not specifically reported, but > 12 years of school was
also disproportionate between groups: index 33.9%, refer-
ence 45.1%
Disease severity was incomparable in the index group
(HIV+ persons) and reference group (healthy and undiag-
nosed, asymptomatic HIV+ people)
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Larson 2013
Methods CBA study
Participants Index: 237 HIV+ tea pluckers with a CD4 count < 350 who began ART between 2004
and 2007
Control: Pool of workers from the 13,178 general work force population
(Kenya)
Interventions Intervention: Pharmacological, ART
Control: Healthy, untreated general work force
Outcomes Employment:
1. Total days working per month
2. Days spent plucking tea per month
3. Total kg of tea harvested per month
4. Total income per month
Notes HIV
Risk of bias
Bias Authors’ judgement Support for judgement
14. Blinding (Subjects) Low risk Participants were unaware of intervention.
15. Blinding (outcome assessors) Low risk Not reported. Objective outcomes that should have been unaf-
fected by blinding
16. Retrospective unplanned subgroup
analysis
Unclear risk Retrospective study, data dredging not clear.
17. Follow-up Low risk Follow-ups conducted for both index and reference at 6-month
intervals beginning 24 months pre-ART until 24 months post-
ART
18. Statistical tests Low risk Mean difference (95% confidence interval)
19. Compliance Unclear risk Compliance to ART was not monitored or insured. ART ad-
herence is required for survival, therefore compliance is highly
likely
20. Outcome measures Low risk All predetermined outcome measures were analyzed and re-
ported
21. Selection Bias (population) Low risk Study used all HIV+ persons who visited the tea plantation hos-
pitals and healthcare clinics. All participants were employees of
two tea plantations in the Kericho District of Kenya. However,
it is important to note that some participants in the reference
group were likely HIV+ but were undiagnosed or had not de-
clared their HIV status as positive. This could have impacted
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Larson 2013 (Continued)
the results
22. Selection bias (time) Low risk All participants were monitored between 2006-2009.
23. Randomization High risk No randomization for index group. Index group was matched
with four references who were randomized into subestate groups
24. Allocation concealment Unclear risk Retrospective, non-randomized study. Did not report the use of
adequate sequence generation or allocation concealment tech-
niques
25. Adjustment for confounding High risk Adjustment for gender outcome differences. Age differences not
addressed. SES differences not addressed. Disease severity not
addressed. Migration differences not addressed
26. Incomplete outcome data High risk 6%attrition in index group addressed.No attritiondata reported
for controls. Data for workers in the general work force was
incomplete due to a change in themanagement system resulting
in the reassigning of employment identification numbers
Baseline comparability High risk Nobaseline demographics were reported for the reference group.
The index group mean age for women was 39.4 (27.4-53) and
for men was 39.5 (24.9-54.4). The average years of experience
for women was 8.2 (1-24) years and for men was 7.7 (0.5-23)
years. Median baseline CD4 counts for women were 178 (91-
243) and for men were 153.3 (85-215)
Linnemayr 2013
Methods Longitudinal, prospective cohort study (CBA study)
Participants 602 HIV+ treatment-naive clients, 18 years of age or older, who were newly evaluated
for ART from 2 Joint Clinical Research Centres in Kampala (urban) and Kakira (rural)
, Uganda.
Index: 300 HIV+ people initiating ART with CD4 count < 250 cells/mm3 (WHO
disease stage III or IV) and had a ’treatment supporter’
Control: 302 HIV+ people pre-ART with CD4 count < 400 cells/mm3
Interventions All participants underwent structured interview concerning background characteristics,
physical and mental health status, and economic outcomes. Health data abstracted from
patient medical records. Assessments taken at 0 and 12 months
Index: ART provided by Joint Clinical Research Centre HIV Clinic, plus general HIV
treatment
Control: General HIV treatment, no ART
Outcomes Employment:
1. Work status in the week preceding interview
Other health-related economic outcomes:
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Linnemayr 2013 (Continued)
2. Health interference with work (binary indicator of perceived health effect on work)
3. Pain interference with work in last month (5-point scale from ’not at all’ to ’extremely’)
4. Work-related self efficacy (single visual analogue scale 0-10)
Notes Rand Corporation (California, USA)
Joint Clinical Research Centre (Kampala, Uganda)
Funding: The Rockfeller Foundation, Grant No. HE007;PIGWagner
Participants received 5000 Uganda Shillings (~USD 2.50) for completion of each inter-
view
Risk of bias
Bias Authors’ judgement Support for judgement
14. Blinding (Subjects) Unclear risk No blinding, however due to a dichoto-
mous outcome of employed or unem-
ployed in past 7 days, this should not have
affected the results
15. Blinding (outcome assessors) Low risk No blinding, objective outcomes should
have been unaffected by lack of outcome
assessor blinding
16. Retrospective unplanned subgroup
analysis
Low risk No evidence of retrospective unplanned
subgroup analysis.
17. Follow-up Low risk Follow-ups conducted at 6 and 12 months
in both index and reference groups. Ap-
proximately 5% loss to attrition
18. Statistical tests Low risk Two-tailed t-test, Chi2 test (has statistically
lowpower when study has small sample size
(n = 602))
Performed 2 sensitivity analyses:
1. Excluded control-group participants
who began ART treatment but were kept
in the control group due to intention-to-
treat study design analysis
2. Restricted control group to members
of a similar health status
19. Compliance Unclear risk ART adherence is required for survival,
therefore compliance, although not moni-
tored, is highly likely. Eligibility for the in-
dex group required the HIV+ persons have
a ’treatment supporter’ for adherence
20. Outcome measures Low risk All predetermined outcome measures re-
ported.
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Linnemayr 2013 (Continued)
21. Selection Bias (population) Unclear risk Eligible patients were approached by clinic
staff when ART eligibility was assessed. No
randomization. Intention-to-treat analysis
was utilized to avoid control-group mem-
bers changing to the index group
22. Selection bias (time) Unclear risk Recruitment timeline not specified. 2008?
23. Randomization Unclear risk Non-randomized. Participants were prede-
termined to index and reference groups by
ART eligibility status
24. Allocation concealment Unclear risk Non-randomized.Did not report the use of
adequate sequence generation or allocation
concealment techniques
25. Adjustment for confounding Unclear risk Stratified data by gender and included
physical health and mental health con-
founders. Did not account for age, SES, or
education
26. Incomplete outcome data Low risk < 5% attrition, and all outcome data re-
ported.
Baseline comparability Unclear risk As expected, baseline health differences
were present between the index and ref-
erence groups due to disease progression
and need for treatment. However, authors
claim to have performed a sensitivity anal-
ysis and reported that the overall results did
not change. However, data was not pre-
sented in the publication
Martin 2012
Methods RCT
Participants 174 HIV+ persons aged 18-65 who had stopped working due to disability, were receiving
disability services, and who were contemplating rejoining the workforce. (USA)
Index group: 83
Control group: 91
Interventions Intervention:
• 1-hour individual counseling sessions conducted in the beginning, middle, and
end of the 7-week group session period
• 13 group sessions over a period of 7 weeks
Control:
• 1 group session in which participants were given community referrals to assist in
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Martin 2012 (Continued)
returning to work
Outcomes Employment:
1. Full-time, part-time, temporary, or under-the-table paid employment in the past
6 months and average hours per week
2. Unpaid volunteer work in the past 6 months and average hours per week
3. Attendance at job training classes in the past 6 months and average hours per week
4. Active job search for a period of 30 days or longer in the past 6 months
Authors also assessed:
• Demographics in past 6 months
• Current health status
Notes Contacted authors for additional information. None provided.
Risk of bias
Bias Authors’ judgement Support for judgement
14. Blinding (Subjects) High risk No blinding of participants or personnel.
15. Blinding (outcome assessors) High risk Not reported.
16. Retrospective unplanned subgroup
analysis
Unclear risk Only baseline data was reported. No follow-up outcomes pro-
vided
17. Follow-up Low risk Follow-ups conducted for both index and reference groups at 6,
12, 18, and 24 months
18. Statistical tests Unclear risk Unable to determine appropriateness due to unjustified, com-
plex data analysis and unreported follow-up outcome data
19. Compliance High risk Compliance not insured. Dose-response analysis conducted but
results uninterruptible
20. Outcome measures Low risk All predetermined outcome measures were reported.
21. Selection Bias (population) Unclear risk Participantswere recruited frommultiple AIDS service organiza-
tions, communitymental health centers,HIVmedical providers,
and gay and lesbian centers, and may be disproportionate be-
tween index and reference groups, although reported baseline
demographic characteristics were uniform between groups
22. Selection bias (time) Low risk Recruited at same time. Randomized.
23. Randomization Low risk Stratified randomization procedure on education, CD4 count,
and ethnic minority status
24. Allocation concealment Unclear risk Not reported.
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25. Adjustment for confounding High risk Not adjusted for gender; only 9-10% female in both groups.
26. Incomplete outcome data High risk All follow-up outcomedatamissing.Only baseline data provided
with generalized summaries in results section
Nannungi 2013
Methods Longitudinal, prospective cohort Study (CBA study)
Participants 482 participants were recruited (July 2008 to August 2009) as consecutive, new clinic
patients recently evaluated for ART from 2HIV clinics in Kampala, Uganda (Reach Out
Mbuya and Mulago Immune Suppression Syndrome Clinic)
Index: 257 HIV+ persons initiating ART with CD4 count < 250 cells/mm3(WHO
disease stage III or IV)
Control: 225 HIV+ persons pre-ART with CD4 count < 400 cells/mm3
Interventions All participants received HIV primary medical care (monitoring and treatment of infec-
tions and prescription of prophylactic medications)
Index: ART plus HIV primary medical care
Control: HIV primary medical care
Outcomes All participants underwent structured interview concerning background characteristics,
physical and mental health status, and economic outcomes. Health data abstracted from
patient medical records and Medical Outcomes Study HIV Health Survey. Assessments
taken at 0, 6, and 12 months
Employment:
1. Work status; having engaged in work activity in previous 7 days (binary yes or no)
2. Weekly income; last payment and number of weeks worked for this payment
Other health-related economic outcomes:
3. Health interefence with ability to work in last month (4-point scale from ’never’ to
’most of the time’)
Notes Infectious Diseases Institute Makerere University (Kampala, Uganda)
Uganda National Council of Science and Technology (Uganda)
Rand Corporation (CA, USA)
Participants received 6000 Uganda Shillings (~USD 2.50) for completion of each assess-
ment
Risk of bias
Bias Authors’ judgement Support for judgement
14. Blinding (Subjects) Unclear risk No blinding, however due to a dichoto-
mous outcome of employed or unem-
ployed in past 7 days, this should not have
affected the results
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Nannungi 2013 (Continued)
15. Blinding (outcome assessors) Low risk No blinding, objective outcomes should
have been unaffected by lack of outcome
assessor blinding
16. Retrospective unplanned subgroup
analysis
Low risk No evidence of retrospective unplanned
subgroup analysis.
17. Follow-up Unclear risk Follow-up conducted at 0, 6, and 12
months. 36% attrition.
18. Statistical tests Low risk Two-tailed t-tests, Chi2 tests, paired t-test,
McNemar’s test.
19. Compliance Unclear risk As ART adherence is required for survival,
compliance, although not monitored. is
highly likely
20. Outcome measures Low risk All predetermined outcome measures were
reported.
21. Selection Bias (population) Low risk Non-randomized, non-blinded recruit-
ment of consecutive new clinic clients re-
cently evaluated for ART
22. Selection bias (time) Low risk All participant recruitment July 2008 to
August 2009.
23. Randomization Low risk Non-randomized, ART group and control
group predetermined by health status and
WHO stages of disease criteria
24. Allocation concealment High risk Non-randomization. Did not report the
use of adequate sequence generation or al-
location concealment techniques
25. Adjustment for confounding Unclear risk Study adjusted for changes in physical
health status, age, gender, education, rela-
tionship status, and CD4 count. However,
did not account for SES or mental health
confounders
26. Incomplete outcome data Unclear risk 36% attrition, analysis included attrition
weights for dropouts derived from study
completion and baseline measures associ-
ated with ART
Baseline comparability High risk As expected, baseline health differences
were present between the index and refer-
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Nannungi 2013 (Continued)
ence groups due to disease progression and
need for treatment. Higher percentage of
index group was married or in a commit-
ted relationship than control group.Higher
percentage of control group working and
higher weekly income at baseline than in-
dex group. Analysis adjusted for change in
physical health status
Thirumurthy 2011
Methods CBA study
Participants 1543 adult HIV+ persons, plus 54 caretakers and 67 children (Tamil Nadu, India)
Index Group: 515
Control Group: 723
A total of 1238 participants were included in the final analysis
Interventions Intervention: Pharmacological, ART and home visits for ART adherence support
• Clinical care: routine medical care, diagnosis, and treatment of opportunistic
infections
• Nutritional supplement: nutritional assessment, counseling, macronutrient/
micronutrient supplements
• Home-based care: home visits for encouraging participants to make monthly
hospital visits, social service connection for income-generating activities, legal services,
and housing
Control: All of the above except for ART and home visits for ART adherence support
because CD4 counts were above 200 and ART was not indicated
Outcomes Employment:
1. Whether participants took part in economic activities during the week prior to
interview
2. Number of hours they worked during the week prior to interview
3. Individual income earned in the past 30 days
4. Individual income earned in the past 6 months
Health status:
1. Body mass index
2. CD4 cell count
3. ART initiation date
Notes ***Participants were not required to be employed at the time of the study, however the
study measured economic outcomes related to ART
Risk of bias
Bias Authors’ judgement Support for judgement
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Thirumurthy 2011 (Continued)
14. Blinding (Subjects) Low risk No blinding, however due to a dichotomous outcome of em-
ployment or non-employment, this should not have affected the
results
15. Blinding (outcome assessors) Low risk No blinding. Objective outcomes that should have been unaf-
fected by blinding
16. Retrospective unplanned subgroup
analysis
Low risk No additional analysis.
17. Follow-up Low risk Same time period. 68.66% present for interviews at 24 months
18. Statistical tests Unclear risk Mean difference and standard error. Contacted authors for fur-
ther interpertation but did not receive response
19. Compliance Unclear risk Compliance to ART was not reported. However, ART partic-
ipants did receive home visits to encourage ART adherence.
ART adherence is required for survival, therefore compliance,
although not monitored, is likely
20. Outcome measures Low risk All previously determined outcomes were reported.
21. Selection Bias (population) Low risk Selected from same population. (Tamil Nadu Family Contin-
uum Care Program)
22. Selection bias (time) Low risk Recruited at the same time.
23. Randomization High risk Non-randomized study. Participants were predetermined by
health status and CD4 counts
24. Allocation concealment Unclear risk Non-randomized.
25. Adjustment for confounding High risk Adjusted for gender. No adjustment for differences in disease
severity.No adjustments for differences for SES.No adjustments
for differences in age
26. Incomplete outcome data Unclear risk 34.34% attrition in index group addressed. No attrition data
reported for controls
Baseline comparability Unclear risk Female percentage was 42% in the index group and 65% in the
reference group. Percentage of those who completed secondary
education was 28% in the index group and 27% in the reference
group. CD4 counts at baseline were 128.2 for the index group
and 465.6 for the reference group
ART: antiretroviral therapy
CBA: controlled before-after study
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HIV+ persons: persons living with HIV
RCT: randomized controlled trial
SES: socioeconomic status
WHO: World Health Organization
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ajithkumar 2007 No control group.
Bernell 2005 Not a RCT or CBA study.
Escovitz 2005 Kirk Employment Empowerment Project. No control group.
Goldman 2004 No control group.
Herdt 1999 Study about AIDS prevention; not an HIV employment outcome intervention
Hergenrather 2013 No control group.
Lee 2005 We sought unpublished raw data specific to HIV from the author but received none. The published data
on general chronic diseases was not relevant to the other studies in the review
Martin 2003 Not an intervention study.
Martin 2005 Summary of ongoing study later published as Martin 2012.
Maticka-Tyndale 2002 All results were qualitative.
Resch 2011 Non-intervention, modeling study.
Rosen 2004 Not an intervention study.
Rosen 2010 No control group.
Rosen 2014 No control group.
Rosolen 2002 Not an intervention study.
Rueda 2012 Not an intervention study.
Thirumurthy 2013 Not an intervention study.
Van der Borght 2006 Not a RCT or CBA study.
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(Continued)
Van der Borght 2010 Not a RCT or CBA study.
CBA: controlled before-after study
RCT: randomized controlled trial
Characteristics of studies awaiting assessment [ordered by study ID]
Baran 2012
Methods Controlled before-after study
Participants 196,350 employees >18 years of age (USA)
Interventions Intervention: Pharmacological, ART
Outcomes Employment:
1. Sick leave
2. Short-term disability
3. Long-term disability
ART cost
Notes Poster presentation only. Contact author for full text and further unpublished outcome data. However, the author
responded that he was unable to provide any unpublished data without the specific permission of AbbVie Pharma-
ceutical Group. AbbVie was contacted for authorization. Richard from AbbVie group is investigating my request.
AbbVie would not release data for external publication or use
Borwein 2010
Methods Not known
Participants Not known
Interventions Not known
Outcomes Not known
Notes Original search produced only abstracts. Contacted author but received no response. Additionally NM sought hard
copies in Canada, and only poster abstracts were located from the Canadian Journal of Infectious Diseases & Medical
Microbiology. Study was still in progress in 2010, but no further publication has been made
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Paul-Ward 2005
Methods Not known
Participants 48 HIV+ people from supportive living facilities (USA)
Interventions Intervention: ESD program
Outcomes Not known
Notes Study still in progress as of 2005. No later publication found. Contacted author but received no response
Popiel 2010
Methods Not known
Participants Not known
Interventions Not known
Outcomes Not known
Notes Original search produced only abstracts. Contacted author but received no response. Additionally NM sought
hard copies in Canada, and only abstracts were located from the Canadian Journal of Infectious Diseases & Medical
Microbiology.
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D A T A A N D A N A L Y S E S
Comparison 1. HIV+ utilizing ART versus healthy (non-HIV+)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Regaining Employment 1 Odds Ratio (Fixed, 95% CI) Totals not selected
1.1 8-5 years pre-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 2-1.5 years pre-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.3 0.5-0.0 years pre-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.4 0.0-0.5 years post-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.5 0.5-1 year post-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.6 1.5-2 years post-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
1.7 3.5-4 years post-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Days working per month 1 Mean Difference (Fixed, 95% CI) Totals not selected
2.1 24-19 months pre-ART 1 Mean Difference (Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 6-1 months pre-ART 1 Mean Difference (Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 0 months 1 Mean Difference (Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 1-6 months post-ART 1 Mean Difference (Fixed, 95% CI) 0.0 [0.0, 0.0]
2.5 19-24 months post-ART 1 Mean Difference (Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Resides in Surveillance Area 1 Odds Ratio (Fixed, 95% CI) Totals not selected
3.1 5-8 years pre-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 2-1.5 years pre-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 0.5-0.0 years pre-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
3.4 0.0-0.5 years post-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
3.5 0.5-1 year post-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
3.6 1.5-2 years post-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
3.7 3.5-4 years post-ART 1 Odds Ratio (Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Job-loss Spells 1 Hazard Ratio (Fixed, 95% CI) Totals not selected
Comparison 2. HIV+ utilizing ART versus HIV+ pre-ART
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Employment at 12 months
follow-up
2 Odds Ratio (Fixed, 95% CI) 1.75 [1.44, 2.12]
2 Hours worked in past week 1 Mean Difference (Fixed, 95% CI) Totals not selected
2.1 6 months follow-up 1 Mean Difference (Fixed, 95% CI) 0.0 [0.0, 0.0]
2.2 12 months follow-up 1 Mean Difference (Fixed, 95% CI) 0.0 [0.0, 0.0]
2.3 18 months follow-up 1 Mean Difference (Fixed, 95% CI) 0.0 [0.0, 0.0]
2.4 24 months follow-up 1 Mean Difference (Fixed, 95% CI) 0.0 [0.0, 0.0]
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Analysis 1.1. Comparison 1 HIV+ utilizing ART versus healthy (non-HIV+), Outcome 1 Regaining
Employment.
Review: Interventions for improving employment outcomes for workers with HIV
Comparison: 1 HIV+ utilizing ART versus healthy (non-HIV+)
Outcome: 1 Regaining Employment
Study or subgroup log [Odds Ratio] Odds Ratio Odds Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 8-5 years pre-ART
Bor 2012 0.029559 (0.105567) 1.03 [ 0.84, 1.27 ]
2 2-1.5 years pre-ART
Bor 2012 -0.23572 (0.132428) 0.79 [ 0.61, 1.02 ]
3 0.5-0.0 years pre-ART
Bor 2012 -0.69315 (0.132787) 0.50 [ 0.39, 0.65 ]
4 0.0-0.5 years post-ART
Bor 2012 -1.04982 (0.150189) 0.35 [ 0.26, 0.47 ]
5 0.5-1 year post-ART
Bor 2012 -0.96758 (0.163443) 0.38 [ 0.28, 0.52 ]
6 1.5-2 years post-ART
Bor 2012 -0.82098 (0.178087) 0.44 [ 0.31, 0.62 ]
7 3.5-4 years post-ART
Bor 2012 -0.31471 (0.286101) 0.73 [ 0.42, 1.28 ]
0.2 0.5 1 2 5
Favours Healthy ???? Favours ART HIV+
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Analysis 1.2. Comparison 1 HIV+ utilizing ART versus healthy (non-HIV+), Outcome 2 Days working per
month.
Review: Interventions for improving employment outcomes for workers with HIV
Comparison: 1 HIV+ utilizing ART versus healthy (non-HIV+)
Outcome: 2 Days working per month
Study or subgroup Mean Difference (SE)
Mean
Difference
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 24-19 months pre-ART
Larson 2013 -0.05 (0.22959) -0.05 [ -0.50, 0.40 ]
2 6-1 months pre-ART
Larson 2013 -1.28 (0.191327) -1.28 [ -1.65, -0.91 ]
3 0 months
Larson 2013 -8.49 (0.55357) -8.49 [ -9.57, -7.41 ]
4 1-6 months post-ART
Larson 2013 0.08 (0.017857) 0.08 [ 0.05, 0.11 ]
5 19-24 months post-ART
Larson 2013 -1.22 (0.265306) -1.22 [ -1.74, -0.70 ]
-4 -2 0 2 4
Favours ART Favours Healthy
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Analysis 1.3. Comparison 1 HIV+ utilizing ART versus healthy (non-HIV+), Outcome 3 Resides in
Surveillance Area.
Review: Interventions for improving employment outcomes for workers with HIV
Comparison: 1 HIV+ utilizing ART versus healthy (non-HIV+)
Outcome: 3 Resides in Surveillance Area
Study or subgroup log [Odds Ratio] Odds Ratio Odds Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
1 5-8 years pre-ART
Bor 2012 -0.21072 (0.16335) 0.81 [ 0.59, 1.12 ]
2 2-1.5 years pre-ART
Bor 2012 0.277632 (0.210327) 1.32 [ 0.87, 1.99 ]
3 0.5-0.0 years pre-ART
Bor 2012 0.993252 (0.210435) 2.70 [ 1.79, 4.08 ]
4 0.0-0.5 years post-ART
Bor 2012 1.410987 (0.229429) 4.10 [ 2.62, 6.43 ]
5 0.5-1 year post-ART
Bor 2012 1.247032 (0.323065) 3.48 [ 1.85, 6.55 ]
6 1.5-2 years post-ART
Bor 2012 1.363537 (0.256787) 3.91 [ 2.36, 6.47 ]
7 3.5-4 years post-ART
Bor 2012 0.824175 (0.422654) 2.28 [ 1.00, 5.22 ]
0.1 0.2 0.5 1 2 5 10
Favours ??? Favours ????
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Analysis 1.4. Comparison 1 HIV+ utilizing ART versus healthy (non-HIV+), Outcome 4 Job-loss Spells.
Review: Interventions for improving employment outcomes for workers with HIV
Comparison: 1 HIV+ utilizing ART versus healthy (non-HIV+)
Outcome: 4 Job-loss Spells
Study or subgroup log [Hazard Ratio] Hazard Ratio Hazard Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
Bor 2012 -0.12783 (0.11761096) 0.88 [ 0.70, 1.11 ]
0.5 0.7 1 1.5 2
Favours Healthy Favours ART
Analysis 2.1. Comparison 2 HIV+ utilizing ART versus HIV+ pre-ART, Outcome 1 Employment at 12
months follow-up.
Review: Interventions for improving employment outcomes for workers with HIV
Comparison: 2 HIV+ utilizing ART versus HIV+ pre-ART
Outcome: 1 Employment at 12 months follow-up
Study or subgroup log [Odds Ratio] Odds Ratio Weight Odds Ratio
(SE) IV,Fixed,95% CI IV,Fixed,95% CI
Linnemayr 2013 0.6313 (0.1258) 60.5 % 1.88 [ 1.47, 2.41 ]
Nannungi 2013 0.4447 (0.1556) 39.5 % 1.56 [ 1.15, 2.12 ]
Total (95% CI) 100.0 % 1.75 [ 1.44, 2.12 ]
Heterogeneity: Chi2 = 0.87, df = 1 (P = 0.35); I2 =0.0%
Test for overall effect: Z = 5.70 (P < 0.00001)
Test for subgroup differences: Not applicable
0.2 0.5 1 2 5
Favours pre-ART Favours ART
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Analysis 2.2. Comparison 2 HIV+ utilizing ART versus HIV+ pre-ART, Outcome 2 Hours worked in past
week.
Review: Interventions for improving employment outcomes for workers with HIV
Comparison: 2 HIV+ utilizing ART versus HIV+ pre-ART
Outcome: 2 Hours worked in past week
Study or subgroup Mean Difference (SE)
Mean
Difference
Mean
Difference
IV,Fixed,95% CI IV,Fixed,95% CI
1 6 months follow-up
Thirumurthy 2011 11.95 (2.652) 11.95 [ 6.75, 17.15 ]
2 12 months follow-up
Thirumurthy 2011 13.38 (2.625) 13.38 [ 8.24, 18.52 ]
3 18 months follow-up
Thirumurthy 2011 8.561 (2.575) 8.56 [ 3.51, 13.61 ]
4 24 months follow-up
Thirumurthy 2011 12.1 (2.607) 12.10 [ 6.99, 17.21 ]
-20 -10 0 10 20
Favours Pre-ART Favours ART
A D D I T I O N A L T A B L E S
Table 1. GRADE ratings for determining the quality of the evidence
Comparison Limitations
(Risk of bias
in studies)
Directness of
evidence
Consistency
between
studies
Precision of
effect size
Publication
bias
Consider-
ations for up-
grading obser-
vational stud-
ies
Level of Evi-
dence
HIV+ ART
vs. Healthy (2
Studies)
HIGH risk of
bias. Non-
random-
ized retrospec-
tive studies
of cohort data.
Non-blinded
but
should not af-
fect the results
of the study as
No limita-
tions. Popula-
tions in com-
par-
ison: Kenyan
tea work-
ers (predomi-
nate employer
in district) &
South African
general popu-
Results consis-
tent in both
studies. Sub-
group analysis
was not appli-
cable
NO DOWN-
GRADE
Wide con-
fidence inter-
vals.
DOWN-
GRADE
Not applica-
ble; only two
studies.
NO DOWN-
GRADE
Small
intervention
partic-
ipant numbers
potentially in-
flate the mag-
nitude of the
effect
Dose-effect re-
lation was not
VERY LOW
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Table 1. GRADE ratings for determining the quality of the evidence (Continued)
outcomes are
objective. Low
risk of selec-
tion bias. Low
rate of attri-
tion for index
groups. High
risk of bias for
adjustments
for confound-
ing. Lack of at-
trition data for
the
control group.
High risk of
bias for base-
line compara-
bil-
ity. DOWN-
GRADE
lation in sub-
district. Direct
popu-
lations, direct
ART interven-
tions delivered
through clin-
ics, and
healthy
control group
received no in-
tervention.
No surrogate
data was used
NO DOWN-
GRADE
explored as no
data on dosage
was provided
Noanalysis for
confounders.
NO
UPGRADE
HIV+
ART vs. Pre-
ART (3 Stud-
ies)
HIGH risk of
bias. Non-
randomized
prospective
cohort studies.
No blinding,
however
results should
be unaffected
due to objec-
tive, dichoto-
mous out-
comes. Low
risk of selec-
tion bias. Low
rate of attri-
tion for index.
Unclear risk
for a lack of
attrition data
for the control
groups. High
risk of bias for
baseline com-
parabil-
ity. DOWN-
GRADE
No outlying,
indirect ev-
idence. Con-
trol groups re-
ceived
standard care.
No surrogate
data used in
any study
NO DOWN-
GRADE
Results consis-
tent in all 3
studies.
NO DOWN-
GRADE
NO DOWN-
GRADE
All 3 studies
produced evi-
dence of the
positive effect
of ART on
employment,
how-
ever we did
not judge this
to be biased
to file drawer
phenomenon.
None
of the studies
had pharma-
ceutical fund-
ing
or any known
conflicts of in-
terest
NO DOWN-
GRADE
Small
intervention
partic-
ipant numbers
potentially in-
flate the mag-
nitude of the
effect
Dose-effect re-
lation was not
explored as no
data on dosage
was provided
Incomplete
analysis for
confounders.
Studies in-
dividually ad-
justed for dif-
ferent and
limited
confounders
NO
UPGRADE
VERY LOW
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Table 1. GRADE ratings for determining the quality of the evidence (Continued)
Vocational
Interven-
tion vs. None
(1 study)
High risk of
bias. Al-
location con-
cealment and
loss to follow-
up not
reported. No
blinding and
evidence of se-
lective report-
ing
DOWN-
GRADE
No
outlying, indi-
rect evidence
due to single-
study compar-
ison. Control
group received
standard care.
Outcome
data limi-
tations due to
missing fol-
low-up data
and complex,
confusing re-
porting.
DOWN-
GRADE
Only one
study;
complete ho-
mogeneity
NO DOWN-
GRADE
Poorly re-
ported, mini-
mal outcome
data.
DOWN-
GRADE
No evidence
of publication
bias.
NO DOWN-
GRADE
Randomized
study.
NOT APPLI-
CABLE
VERY LOW
A P P E N D I C E S
Appendix 1. MEDLINE (PubMed) search strategy
14 March 2012 (by Leena Isotalo)
#1 HIV Infections[MeSH] ORHIV[MeSH] OR hiv[tw] OR hiv-1*[tw] OR hiv-2*[tw] OR hiv1[tw] OR hiv2[tw] OR hiv infect*[tw]
OR human immunodeficiency virus[tw] OR human immunedeficiency virus[tw] OR human immuno-deficiency virus[tw] ORhuman
immune-deficiency virus[tw] OR ((human immun*[tw]) AND (deficiency virus[tw])) OR acquired immunodeficiency syndrome[tw]
OR acquired immunedeficiency syndrome[tw] OR acquired immuno-deficiency syndrome[tw] OR acquired immune-deficiency syn-
drome[tw] OR ((acquired immun*[tw]) AND (deficiency syndrome[tw])) OR HIV/AIDS[tw]
#2 absenteeism[tw] OR absenteeism [MeSH] OR “work disability”[tw] OR “sick leave”[tw] OR “sick leave”[MeSH] OR “sickness ab-
sence”[tw]OR employment [MeSH]OR employment [tw] OR “re-employment”[tw] ORunemployment [MeSH]ORunemployment
[tw] OR unemployed[tw] OR employability[tw] OR employable[tw] OR employee*[tw] OR “work capacity”[tw] OR “occupational
health”[MesH] OR “occupational health services” [MeSH] OR “return to work”[tw] OR “retirement”[tw] OR “work status”[tw] OR
“occupational medicine”[MeSH] OR “job satisfaction”[tw] OR “work ability”[tw] OR workability[tw] OR “work activity”[tw] OR
“work retention”[tw] OR “job retention”[tw] OR “job loss”[tw] OR “job performance”[tw] OR “rehabilitation, vocational”[MeSH]
OR “work rehabilitation”[tw]
#3 (work[ti] OR worker*[tw] OR worki*[tw] OR workplace*[tw] OR worksite*[tw] OR occupation*[tw] OR “Occupational
Groups”[Mesh]) AND (“disability management”[tw] OR “Rehabilitation”[Mesh:NoExp] OR “rehabilitation” [Subheading] OR “psy-
chological intervention”[tw] OR “psychological interventions”[tw] OR “motivational interviewing” [tw] OR “self management”[tw]
OR “behaviour change”[tw] OR “Occupational Therapy”[Mesh]) OR “work accommodation”[tw] OR “work modification”[tw]
#4 #1 AND (#2 OR #3)
#5 randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR placebo[tiab] OR drug therapy[sh] OR
randomly[tiab] OR trial[tiab] OR groups[tiab] NOT (animals [mh] NOT humans [mh])
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#6 (effect*[tw] OR control[tw] OR controls*[tw] OR controla*[tw] OR controle*[tw] OR controli*[tw] OR controll*[tw] OR evalu-
ation*[tw] OR program*[tw]) OR “Cohort Studies”[Mesh] OR “Intervention Studies”[Mesh] OR “Comparative Study” [Publication
Type] OR “Evaluation Studies as Topic”[Mesh:NoExp] OR “Evaluation Studies” [Publication Type] OR “follow up”[tw]
#7 #4 AND #5
#8 #4 AND #6
#9 #7 OR #8
Updated Search 9 December 2014 (by Kaisa Neuvonen)
Search Query Items found
#10 #9 AND (“2013/11/06”[Date - Entrez] : “3000”[Date - En-
trez])
154
#9 #7 OR #8 3 249
#8 #4 AND #6 3 018
#7 #4 AND #5 1 033
#6 (effect*[tw] OR control[tw] OR controls*[tw] OR con-
trola*[tw] OR controle*[tw] OR controli*[tw] OR con-
troll*[tw] OR evaluation*[tw] OR program*[tw]) OR “Co-
hort Studies”[Mesh] OR “Intervention Studies”[Mesh] OR
“Comparative Study” [Publication Type] OR “Evaluation
Studies as Topic”[Mesh:NoExp] OR “Evaluation Studies”
[Publication Type] OR “follow up”[tw]
11 397 938
#5 randomized controlled trial[pt] OR controlled clinical
trial[pt] OR randomized[tiab] OR placebo[tiab] OR
drug therapy[sh] OR randomly[tiab] OR trial[tiab] OR
groups[tiab] NOT (animals [mh] NOT humans [mh])
2 993 018
#4 #1 AND (#2 OR #3) 4 626
#3 (work[ti] OR worker*[tw] OR worki*[tw] OR work-
place*[tw] OR worksite*[tw] OR occupation*[tw] OR
“Occupational Groups”[Mesh]) AND (“disability manage-
ment”[tw] OR “Rehabilitation”[Mesh:NoExp] OR “rehabil-
itation” [Subheading] OR “psychological intervention”[tw]
OR “psychological interventions”[tw] OR “motivational in-
terviewing” [tw] OR “self management”[tw] OR “behaviour
change”[tw]OR “Occupational Therapy”[Mesh])OR “work
accommodation”[tw] OR “work modification”[tw]
30 610
#2 absenteeism[tw] OR absenteeism [MeSH] OR “work dis-
ability”[tw] OR “sick leave”[tw] OR “sick leave”[MeSH]
OR “sickness absence”[tw] OR employment [MeSH] OR
employment [tw] OR “re-employment”[tw] OR unem-
ployment [MeSH] OR unemployment [tw] OR unem-
ployed[tw] OR employability[tw] OR employable[tw] OR
226 105
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(Continued)
employee*[tw] OR “work capacity”[tw] OR “occupational
health”[MesH] OR “occupational health services” [MeSH]
OR “Return to work”[MeSH] OR “return to work”[tw]
OR “retirement”[tw] OR “work status”[tw] OR “occu-
pational medicine”[MeSH] OR “job satisfaction”[tw] OR
“work ability”[tw] OR workability[tw] OR “work activ-
ity”[tw] OR “work retention”[tw] OR “job retention”[tw]
OR “job loss”[tw] OR “job performance”[tw] OR “rehabili-
tation, vocational”[MeSH] OR “work rehabilitation”[tw]
#1 HIV Infections[MeSH] OR HIV[MeSH] OR hiv[tw] OR
hiv-1*[tw] OR hiv-2*[tw] ORhiv1[tw] ORhiv2[tw] ORhiv
infect*[tw] OR human immunodeficiency virus[tw] OR hu-
man immunedeficiency virus[tw] OR human immuno-de-
ficiency virus[tw] OR human immune-deficiency virus[tw]
OR ((human immun*[tw]) AND (deficiency virus[tw])) OR
acquired immunodeficiency syndrome[tw] OR acquired im-
munedeficiency syndrome[tw] OR acquired immuno-defi-
ciency syndrome[tw] OR acquired immune-deficiency syn-
drome[tw] OR ((acquired immun*[tw]) AND (deficiency
syndrome[tw])) OR HIV/AIDS[tw]
325 944
Appendix 2. Cochrane Central Register of Controlled Trials (CENTRAL) search strategy
9 October 2012 (by Leena Isotalo)
#1 hiv or “hiv-1*” or “hiv-2*” or hiv1 or hiv2 or “hiv infect*” or “human immunodeficiency virus” or “human immunedeficiency
virus” or “human immuno-deficiency virus” or “human immune-deficiency virus”:ti,ab,kw (Word variations have been searched)
9102
#2 MeSH descriptor: [HIV] explode all trees
2250
#3 MeSH descriptor: [HIV Infections] explode all trees
6728
#4 (“human immun*” and “deficiency virus”) or “acquired immunodeficiency syndrome” or “acquired immunedeficiency syndrome”
or “acquired immuno-deficiency syndrome” or “acquired immune-deficiency syndrome” or (“acquired immun*” and “deficiency
syndrome”) or “HIV/AIDS”
2340
#5 #1 or #2 or #3 or #4
9863
#6 MeSH descriptor: [Absenteeism] explode all trees
370
#7 MeSH descriptor: [Sick Leave] explode all trees
334
#8 MeSH descriptor: [Employment] explode all trees
958
#9 MeSH descriptor: [Unemployment] explode all trees
54
#10 MeSH descriptor: [Occupational Health] explode all trees
318
#11 MeSH descriptor: [Occupational Health Services] explode all trees
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#12 MeSH descriptor: [Occupational Medicine] explode all trees
57
#13 MeSH descriptor: [Rehabilitation, Vocational] explode all trees
305
#14 absenteeism or “work disability” or “sick leave” or “sickness absence” or employment or “re-employment” or unemployment or
unemployed or employability or employable or employee* or “work capacity” or “return to work” or “retirement” or “work status”
or “job satisfaction” or “work ability” or workability or “work activity” or “work retention” or “job retention” or “job loss” or “job
performance” or “work rehabilitation”
6822
#15 #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14
7297
#16 MeSH descriptor: [Occupational Groups] explode all trees
5326
#17 MeSH descriptor: [Rehabilitation] this term only
270
#18 Any MeSH descriptor with qualifier(s): [Rehabilitation - RH] in all MeSH products
11494
#19 MeSH descriptor: [Occupational Therapy] explode all trees
452
#20 work*:ti (Word variations have been searched)
4338
#21 worker* or worki* or workplace* or worksite* or occupation*
16400
#22 “psychological intervention” or “psychological interventions” or “motivational interviewing” or “self management” or “behaviour
change” or accommodation or modification
12075
#23 #16 or #20 or #21
22100
#24 “disability management”
18
#25 #17 or #18 or #19 or #22 or #24
23331
#26 #23 and #25
3171
#27 #15 or #26
9556
#28 #5 and #27
245
limited to:
Cochrane Central Register of Controlled Trials (Central)
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Appendix 3. EMBASE search strategy
20 September 2012 (by Leena Isotalo)
(#1) ’human immunodeficiency virus infection’/exp OR ’human immunodeficiency virus’/exp OR hiv:ab,ti OR ’hiv-1’:ab,ti OR ’hiv-
2’:ab,ti OR ’human immunodeficiency virus’:ab,ti OR ’human immuno-deficiency virus’:ab,ti OR ’human immunedeficiency virus’:
ab,ti OR ’human immune-deficiency virus’:ab,ti OR ’acquired immune-deficiency syndrome’:ab,ti OR ’acquired immunedeficiency
syndrome’:ab,ti OR ’acquired immunodeficiency syndrome’:ab,ti OR ’acquired immuno-deficiency syndrome’:ab,ti OR ’hiv/aids’:ab,ti
364,281
(#2) ’absenteeism’/deOR ’medical leave’/deOR ’work disability’/deOR ’employment’/expOR ’unemployment’/deOR ’work capacity’/
deOR ’occupational health’/deOR ’employability’/deOR ’job accommodation’/de OR ’vocational rehabilitation’/de OR ’occupational
health service’/deOR ’occupational health nursing’/deOR ’occupationalmedicine’/deOR ’industrial medicine’/deOR ’job adaptation’/
de OR ’retirement’/de OR ’job satisfaction’/de OR ’job performance’/de OR absenteeism:ab,ti OR ’work disability’:ab,ti OR ’sick
leave’:ab,ti OR ’sickness absence’:ab,ti OR employment:ab,ti OR ’re-employment’:ab,ti OR unemployment:ab,ti OR unemployed:ab,ti
OR employability:ab,ti OR employable:ab,ti OR employee*:ab,ti OR ’work capacity’:ab,ti OR ’occupational health services’:ab,ti OR
’return to work’:ab,ti OR retirement:ab,ti OR ’work status’:ab,ti OR ’job satisfaction’:ab,ti OR ’work ability’:ab,ti OR workability:ab,ti
OR ’work activity’:ab,ti OR ’work retention’:ab,ti OR ’job retention’:ab,ti OR ’job loss’:ab,ti OR ’job performance’:ab,ti OR ’vocational
rehabilitation’:ab,ti OR ’work rehabilitation’:ab,ti OR ’work accommodation’:ab,ti OR ’work modification’:ab,ti
238,611
(#3) work*:ab,ti OR occupation*:ab,ti OR ’work environment’/de OR ’work’/de OR ’workplace’/exp OR ’occupation and occupation
related phenomena’/de OR ’occupation’/exp OR ’occupational health’/exp AND (’disability management’:ab,ti OR rehabilitation:
de,ab,ti OR ’psychological intervention’:ab,ti OR ’psychological interventions’:ab,ti OR ’motivational interviewing’:ab,ti OR ’self
management’:ab,ti OR behavio* NEAR/3 chang* OR ’occupational therapy’)
52,567
(#4) #1 AND (#2 OR #3)
5,044
(#5) random*OR factorial* OR crossover*OR crossNEXT/1 over*ORplacebo*ORdoubl* NEAR/1 blind*OR singl* NEAR/1 blind
OR assign* OR allocat* OR volunteer* OR ’crossover procedure’/de OR ’double-blind procedure’/de OR ’single-blind procedure’/de
OR ’randomized controlled trial’/de
1,405,159
(#6) effect* OR control* OR evaluation* OR program* OR ’cohort analysis’/de OR ’intervention study’/de OR ’comparative study’/
de OR ’comparative effectiveness’/de OR ’intermethod comparison’/de OR ’follow up’
12,732,170
(#7) #4 AND #5
456
(#8) #4 AND #6
3,435
(#9) #7 OR #8
3,497
(#10) ’editorial’/it OR ’letter’/it OR ’note’/it OR ’short survey’/it OR ’nonhuman’/de
5,767,119
(#11) #9 NOT #10
3,228
(#12) #11 AND [embase]/lim
2,110
Updated Search 9 December 2014 (by Kaisa Neuvonen)
(#1) ’human immunodeficiency virus infection’/exp OR ’human immunodeficiency virus’/exp OR hiv:ab,ti OR ’hiv-1’:ab,ti OR ’hiv-
2’:ab,ti OR ’human immunodeficiency virus’:ab,ti OR ’human immuno-deficiency virus’:ab,ti OR ’human immunedeficiency virus’:
ab,ti OR ’human immune-deficiency virus’:ab,ti OR ’acquired immune-deficiency syndrome’:ab,ti OR ’acquired immunedeficiency
syndrome’:ab,ti OR ’acquired immunodeficiency syndrome’:ab,ti OR ’acquired immuno-deficiency syndrome’:ab,ti OR ’hiv/aids’:ab,ti
404,528
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(#2) ’absenteeism’/deOR ’medical leave’/deOR ’work disability’/deOR ’employment’/expOR ’unemployment’/deOR ’work capacity’/
deOR ’occupational health’/deOR ’employability’/deOR ’job accommodation’/de OR ’vocational rehabilitation’/de OR ’occupational
health service’/deOR ’occupational health nursing’/deOR ’occupationalmedicine’/deOR ’industrial medicine’/deOR ’job adaptation’/
de OR ’retirement’/de OR ’job satisfaction’/de OR ’job performance’/de OR absenteeism:ab,ti OR ’work disability’:ab,ti OR ’sick
leave’:ab,ti OR ’sickness absence’:ab,ti OR employment:ab,ti OR ’re-employment’:ab,ti OR unemployment:ab,ti OR unemployed:ab,ti
OR employability:ab,ti OR employable:ab,ti OR employee*:ab,ti OR ’work capacity’:ab,ti OR ’occupational health services’:ab,ti OR
’return to work’:ab,ti OR retirement:ab,ti OR ’work status’:ab,ti OR ’job satisfaction’:ab,ti OR ’work ability’:ab,ti OR workability:ab,ti
OR ’work activity’:ab,ti OR ’work retention’:ab,ti OR ’job retention’:ab,ti OR ’job loss’:ab,ti OR ’job performance’:ab,ti OR ’vocational
rehabilitation’:ab,ti OR ’work rehabilitation’:ab,ti OR ’work accommodation’:ab,ti OR ’work modification’:ab,ti
262,028
(#3) work*:ab,ti OR occupation*:ab,ti OR ’work environment’/de OR ’work’/de OR ’workplace’/exp OR ’occupation and occupation
related phenomena’/de OR ’occupation’/exp OR ’occupational health’/exp AND (’disability management’:ab,ti OR rehabilitation:
de,ab,ti OR ’psychological intervention’:ab,ti OR ’psychological interventions’:ab,ti OR ’motivational interviewing’:ab,ti OR ’self
management’:ab,ti OR behavio* NEAR/3 chang* OR ’occupational therapy’)
61,328
(#4) #1 AND (#2 OR #3)
5,936
(#5) random*OR factorial* OR crossover*OR crossNEXT/1 over*ORplacebo*ORdoubl* NEAR/1 blind*OR singl* NEAR/1 blind
OR assign* OR allocat* OR volunteer* OR ’crossover procedure’/de OR ’double-blind procedure’/de OR ’single-blind procedure’/de
OR ’randomized controlled trial’/de
1,674,549
(#6) effect* OR control* OR evaluation* OR program* OR ’cohort analysis’/de OR ’intervention study’/de OR ’comparative study’/
de OR ’comparative effectiveness’/de OR ’intermethod comparison’/de OR ’follow up’
12,986,661
(#7) #4 AND #5
575
(#8) #4 AND #6
3,588
(#9) #7 OR #8
3,686
(#10) ’editorial’/it OR ’letter’/it OR ’note’/it OR ’short survey’/it OR ’nonhuman’/de
6,412,344
(#11) #9 NOT #10
3,434
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(#12) #11 AND [embase]/lim
2,519
(#13) #11 AND [embase]/lim AND [6-11-2013]/sd NOT [9-12-2014]/sd
354
Appendix 4. OSH UPDATE search strategy
25 September 2012 (by Leena Isotalo)
#1 3152 GW{hiv OR “hiv-1*” OR “hiv-2*” OR hiv1 OR hiv2 OR “HIV/AIDS” ORHUMAN IMMUNODEFICIENCY
VIRUS OR HUMAN IMMUNEDEFICIENCY VIRUS OR HUMAN IMMUNE-DEFICIENCY VIRUS OR
HUMAN IMMUNO-DEFICIENCY VIRUSORHUMAN IMMUN*DEFICIENCY VIRUSORACQUIRED
IMMUNODEFICIENCY SYNDROME OR ACQUIRED IMMUNEDEFICIENCY SYNDROME OR AC-
QUIRED IMMUNO-DEFICIENCY SYNDROMEORACQUIRED IMMUNE-DEFICIENCY SYNDROME
OR ACQUIRED IMMUN* DEFICIENCY SYNDROME}
#2 89805 GW{absenteeism OR work disability OR sick leave OR sickness absence OR employment OR re-employment
OR unemployment OR unemployed OR employability OR employable OR employee* OR work capacity OR
occupational health service* OR return-to-work OR retirement OR work status OR job satisfaction OR work
ability OR workability OR work activity OR work retention OR job retention OR job loss OR job performance
OR vocational rehabilitation OR work rehabilitation}
#3 47230 GW{disabilityOR rehabilitationORpsycholog*ORmotivationalOR selfmanagementORbehaviourORbehavior
OR therapy OR work accommodation OR work modification}
#4 87611 GW{workplace* OR worksite* OR work place* OR work site* OR organisation* OR organization*}
#5 19111 GW{occupation OR occupations}
#6 392334 GW{random* OR trial* OR groups OR effect* OR effici* OR control* OR evaluat* OR program* OR cohort*
OR intervention* OR compar* OR follow-up}
#7 732455 DC{OUCISD OR OUHSEL OR OUNIOC OR OUNIOS OR OURILO}
#8 193459 #2 OR #3 OR #4 OR #5
#9 1355 #1 AND #8
#10 970 #9 AND #6
#11 764 #10 AND #7
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C O N T R I B U T I O N S O F A U T H O R S
RR conducted the abstract appraisal, full-text review, data extraction, data analysis, and article write-up. We divided duplicate investi-
gation of abstracts, full text, data, and article commentary evenly between EO and NM. RR is the guarantor of this review.
D E C L A R A T I O N S O F I N T E R E S T
Rachel Robinson: None known.
Emmanuel Okpo: None known.
Nomusa Mngoma: None known.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The protocol for this review was published under the title, “Work arrangements for sustaining employment in workers with HIV”,
however, we changed the title to “Interventions for improving employment outcomes for workers with HIV” as we considered this title
to more accurately describe the review.
We also included studies that allowed for participants to be unemployed at the time of diagnosis, in order to provide the most
comprehensive picture of employment outcomes by accounting for job loss trends prior to diagnosis. This alteration accounts for the
effects of HIV on employment being prior to diagnosis.
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